#Chr	Start	End	Ref	Alt	Gene.refGene	Func.refGene	ExonicFunc.refGene	GeneDetail.refGene	AAChange.refGene	MAX_MAF	MAX_MAF_ReportedDatabase	GIV_Indian_HOM-VAR	GIV_CDFD_HOM-VAR	Zygosity	Depth	QUAL	FILTER	CADD_phred	MIM_disease.refGene	MIM_id.refGene	InterVar_automated	Orphanet_disorder.refGene	Orphanet_association_type.refGene	Trait_association(GWAS).refGene	HPO_id.refGene	HPO_name.refGene	CLNDN	CLNREVSTAT	CLNSIG	Tissue_specificity(Uniprot).refGene	SIFT_pred	SIFT4G_pred	Polyphen2_HDIV_pred	Polyphen2_HVAR_pred	LRT_pred	MutationTaster_pred	MutationAssessor_pred	FATHMM_pred	PROVEAN_pred	MetaSVM_pred	MetaLR_pred	MetaRNN_pred	M-CAP_pred	PrimateAI_pred	DEOGEN2_pred	BayesDel_addAF_pred	ClinPred_pred	LIST-S2_pred	Aloft_pred	fathmm-MKL_coding_pred	fathmm-XF_coding_pred	Interpro_domain	dbscSNV_ADA_SCORE	dbscSNV_RF_SCORE	Gene damage prediction (all Mendelian disease-causing genes).refGene	Gene damage prediction (Mendelian AD disease-causing genes).refGene	Gene damage prediction (Mendelian AR disease-causing genes).refGene	Expression(egenetics).refGene	Expression(GNF/Atlas).refGene	LoFtool_score.refGene	Essential_gene.refGene	Essential_gene_CRISPR.refGene	Essential_gene_CRISPR2.refGene	Essential_gene_gene-trap.refGene	Gene_indispensability_score.refGene	Gene_indispensability_pred.refGene	MGI_mouse_gene.refGene	MGI_mouse_phenotype.refGene	ZFIN_zebrafish_gene.refGene	ZFIN_zebrafish_structure.refGene	ZFIN_zebrafish_phenotype_quality.refGene	ZFIN_zebrafish_phenotype_tag.refGene	GnomAdExome_AF	GnomAdExome_AF_popmax	GnomAdExome_controls_AF_popmax	GnomAdGenome_AF	GnomAdGenomeAF_popmax	1000g2015aug_all	esp6500siv2_all	Kaviar_AF	abraom_freq	abraom_filter	GME_AF_popmax	GIV_Indian_AAF	GIV_Indian_HET	GIV_CDFD_AAF	GIV_CDFD_HET	#CHROM	POS	ID	REF	ALT	QUAL	FILTER	INFO	FORMAT	LIB1									
chr12	101746745	101746745	A	-	GNPTAB	UTR3	.	NM_024312:c.*419delT	.	0.059441	abraom_freq	NA	NA	het	612	452.6	QD2	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	Mucolipidosis_type_II|Mucolipidosis,_Type_III_Alpha/Beta	criteria_provided,_single_submitter	Uncertain_significance	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	0.0896	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.0064	0.0102	0.0	0.0	0.0009989	0.059441	PASS	0.0					chr12	101746744	.	GA	G	452.6	QD2	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=1.7;AS_FS=1.598;AS_MQ=60;AS_MQRankSum=0;AS_QD=0.36;AS_ReadPosRankSum=-0.7;AS_SOR=0.736;BaseQRankSum=0.53;DP=672;ExcessHet=3.0103;FS=1.257;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=0.86;ReadPosRankSum=-2.367;SOR=0.626	GT:AD:DP:GQ:PL	0/1:446,83:612:99:460,0,11842
chr12	101749532	101749532	T	G	GNPTAB	intronic	.	.	.	0.5324	GnomAdGenome_AF_fin	NA	NA	het	705	7141.64	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	0.0896	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.4444	0.5324	0.439497	0.0	0.408522	0.0		0.0					chr12	101749532	.	T	G	7141.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=3.4;AS_FS=0.52;AS_MQ=60;AS_MQRankSum=0;AS_QD=10.13;AS_ReadPosRankSum=0.4;AS_SOR=0.649;BaseQRankSum=3.44;DP=730;ExcessHet=3.0103;FS=0.52;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=10.13;ReadPosRankSum=0.494;SOR=0.649	GT:AD:DP:GQ:PL	0/1:386,319:705:99:7149,0,8597
chr12	101752020	101752021	AA	-	GNPTAB	intronic	.	.	.	0.0222	GnomAdGenome_AF_fin	NA	NA	het	487	6628.02	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	0.0896	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.004	0.0222	0.0	0.0	0.0001153	0.0		0.0					chr12	101752019	.	TAA	T	6628.02	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=1;AS_FS=17.325;AS_MQ=60;AS_MQRankSum=0;AS_QD=5.78;AS_ReadPosRankSum=1;AS_SOR=0.237;BaseQRankSum=1.65;DP=593;ExcessHet=3.0103;FS=10.122;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.82;ReadPosRankSum=1.81;SOR=0.245	GT:AD:DP:GQ:PL	1/0:89,128:487:99:6645,1729,4543
chr12	101752020	101752020	A	-	GNPTAB	intronic	.	.	.	0.6884	GnomAdGenome_AF_afr	NA	NA	het	487	6628.02	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	0.0896	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.5824	0.6884	0.61262	0.0	0.0001921	0.0		0.0					chr12	101752019	.	TA	T	6628.02	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=0.4;AS_FS=10.633;AS_MQ=60;AS_MQRankSum=0;AS_QD=6.46;AS_ReadPosRankSum=2.1;AS_SOR=0.33;BaseQRankSum=1.65;DP=593;ExcessHet=3.0103;FS=10.122;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.82;ReadPosRankSum=1.81;SOR=0.245	GT:AD:DP:GQ:PL	0/1:89,177:487:99:6645,1597,2736
chr12	101752203	101752203	C	T	GNPTAB	intronic	.	.	.	0.0	GnomAdExome_AF	NA	NA	het	449	6343.64	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	0.0896	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0					chr12	101752203	.	C	T	6343.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=6.2;AS_FS=0.588;AS_MQ=60;AS_MQRankSum=0;AS_QD=14.13;AS_ReadPosRankSum=0.2;AS_SOR=0.722;BaseQRankSum=6.26;DP=485;ExcessHet=3.0103;FS=0.588;MLEAC=1;MLEAF=0.5;MQ=59.96;MQRankSum=0;QD=14.13;ReadPosRankSum=0.243;SOR=0.722	GT:AD:DP:GQ:PL	0/1:195,254:449:99:6351,0,3626
chr12	101753205	101753205	G	A	GNPTAB	intronic	.	.	.	0.5356	GnomAdGenome_AF_fin	25.0	NA	het	591	5131.64	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	not_provided	criteria_provided,_single_submitter	Benign	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	0.0896	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.4445	0.5356	0.438898	0.0	0.406793	0.390734	PASS	0.0	0.23	13.0			chr12	101753205	.	G	A	5131.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=2.9;AS_FS=1.771;AS_MQ=59.95;AS_MQRankSum=-1.8;AS_QD=8.68;AS_ReadPosRankSum=0.6;AS_SOR=0.851;BaseQRankSum=2.95;DP=607;ExcessHet=3.0103;FS=1.771;MLEAC=1;MLEAF=0.5;MQ=59.94;MQRankSum=-1.734;QD=8.68;ReadPosRankSum=0.668;SOR=0.851	GT:AD:DP:GQ:PL	0/1:355,236:591:99:5139,0,8083
chr12	101753254	101753254	A	-	GNPTAB	intronic	.	.	.	0.04529	abraom_freq	NA	0.0	het	584	2112.6	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	0.0896	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.002	0.0065	0.0	0.0	3.84e-05	0.04529	PASS	0.0			0.027778	4.0	chr12	101753253	.	CA	C	2112.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=0.9;AS_FS=1.251;AS_MQ=60;AS_MQRankSum=0;AS_QD=4.33;AS_ReadPosRankSum=-0.5;AS_SOR=0.873;BaseQRankSum=0.797;DP=651;ExcessHet=3.0103;FS=1.766;MLEAC=1;MLEAF=0.5;MQ=59.96;MQRankSum=0;QD=4.39;ReadPosRankSum=-0.321;SOR=0.821	GT:AD:DP:GQ:PL	0/1:349,132:584:99:2120,0,8708
chr12	101753470	101753471	GA	-	GNPTAB	exonic	frameshift deletion	.	GNPTAB:NM_024312:exon19:c.3503_3504del:p.L1168Qfs*5	0.003049	GME_TP	0.0	NA	het	662	6651.6	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	Mucolipidosis_type_II|Pseudo-Hurler_polydystrophy|Inborn_genetic_diseases|GNPTAB-Related_Disorders|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	Pathogenic	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	0.0896	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0005	0.0008	0.0007	0.0003	0.0006	0.0	0.0006	0.0004528	0.000821	PASS	0.003049	0.0005988	1.0			chr12	101753469	.	TGA	T	6651.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-3;AS_FS=1.098;AS_MQ=60;AS_MQRankSum=0;AS_QD=10.05;AS_ReadPosRankSum=1.2;AS_SOR=0.623;BaseQRankSum=-2.924;DP=710;ExcessHet=3.0103;FS=1.098;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=10.05;ReadPosRankSum=1.22;SOR=0.623	GT:AD:DP:GQ:PGT:PID:PL:PS	0|1:368,294:662:99:0|1:101753469_TGA_T:6659,0,14429:101753469
chr12	101757100	101757100	G	C	GNPTAB	intronic	.	.	.	0.9076	GnomAdGenome_AF_eas	100.0	62.0	het	216	1998.64	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	Mucolipidosis_type_II|Pseudo-Hurler_polydystrophy|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	0.0896	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.6106	0.9076	0.690495	0.0	0.110814	0.591133	PASS	0.0	0.648	107.0	0.643885	55.0	chr12	101757100	.	G	C	1998.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=1.2;AS_FS=2.463;AS_MQ=60;AS_MQRankSum=0;AS_QD=9.25;AS_ReadPosRankSum=0.5;AS_SOR=0.887;BaseQRankSum=1.26;DP=223;ExcessHet=3.0103;FS=2.463;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=9.25;ReadPosRankSum=0.562;SOR=0.887	GT:AD:DP:GQ:PL	0/1:130,86:216:99:2006,0,3266
chr12	101757335	101757335	A	G	GNPTAB	intronic	.	.	.	0.4436	GnomAdGenome_AF_fin	12.0	7.0	het	330	3775.64	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	Mucolipidosis_type_II|Pseudo-Hurler_polydystrophy|not_specified|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	0.0896	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.3202	0.3952	0.3963	0.3082	0.4436	0.307508	0.293	0.30107	0.273399	PASS	0.0	0.186	167.0	0.187943	39.0	chr12	101757335	.	A	G	3775.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=0.8;AS_FS=4.917;AS_MQ=60;AS_MQRankSum=0;AS_QD=11.44;AS_ReadPosRankSum=-3;AS_SOR=0.918;BaseQRankSum=0.808;DP=343;ExcessHet=3.0103;FS=4.917;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.44;ReadPosRankSum=-2.908;SOR=0.918	GT:AD:DP:GQ:PL	0/1:171,159:330:99:3783,0,4165
chr12	101757960	101757960	G	C	GNPTAB	intronic	.	.	.	0.4458	GnomAdGenome_AF_fin	2.0	NA	het	180	2370.64	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	0.0896	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.3081	0.4458	0.307508	0.0	0.304672	0.292373	PASS	0.0	0.043	4.0			chr12	101757960	.	G	C	2370.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=3;AS_FS=2.612;AS_MQ=60;AS_MQRankSum=0;AS_QD=13.17;AS_ReadPosRankSum=-1;AS_SOR=0.918;BaseQRankSum=3.07;DP=190;ExcessHet=3.0103;FS=2.612;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.17;ReadPosRankSum=-0.956;SOR=0.918	GT:AD:DP:GQ:PL	0/1:87,93:180:99:2378,0,2055
chr12	101758038	101758039	TT	-	GNPTAB	intronic	.	.	.	0.009	GnomAdGenome_AF_afr	NA	NA	het	82	293.6	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	0.0896	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.0029	0.009	0.0	0.0	0.0	0.0		0.0					chr12	101758037	.	ATT	A	293.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=0.3;AS_FS=2.721;AS_MQ=60;AS_MQRankSum=0.8;AS_QD=1.8;AS_ReadPosRankSum=0.9;AS_SOR=1.244;BaseQRankSum=0.125;DP=133;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=59.14;MQRankSum=-0.696;QD=6.67;ReadPosRankSum=-0.626;SOR=0.693	GT:AD:DP:GQ:PL	0/1:28,16:82:99:301,0,1520
chr12	101758447	101758447	C	T	GNPTAB	intronic	.	.	.	0.9067	GnomAdGenome_AF_eas	NA	NA	het	277	2893.64	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	0.0896	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.6173	0.9067	0.696086	0.0	0.0001537	0.0		0.0					chr12	101758447	.	C	T	2893.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=1.1;AS_FS=4.79;AS_MQ=60;AS_MQRankSum=0.9;AS_QD=10.45;AS_ReadPosRankSum=-0.4;AS_SOR=0.981;BaseQRankSum=1.16;DP=281;ExcessHet=3.0103;FS=4.79;MLEAC=1;MLEAF=0.5;MQ=59.98;MQRankSum=0.921;QD=10.45;ReadPosRankSum=-0.391;SOR=0.981	GT:AD:DP:GQ:PL	0/1:151,126:277:99:2901,0,3527
chr12	101759102	101759102	G	T	GNPTAB	intronic	.	.	.	0.9075	GnomAdGenome_AF_eas	NA	NA	het	185	1868.64	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	0.0896	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.5814	0.9075	0.650759	0.0	0.564162	0.0		0.0					chr12	101759102	.	G	T	1868.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=1.9;AS_FS=0.54;AS_MQ=60;AS_MQRankSum=0.9;AS_QD=10.1;AS_ReadPosRankSum=-0.6;AS_SOR=0.744;BaseQRankSum=1.92;DP=197;ExcessHet=3.0103;FS=0.54;MLEAC=1;MLEAF=0.5;MQ=59.97;MQRankSum=0.913;QD=10.1;ReadPosRankSum=-0.525;SOR=0.744	GT:AD:DP:GQ:PL	0/1:102,83:185:99:1876,0,2198
chr12	101759224	101759224	G	A	GNPTAB	intronic	.	.	.	0.4446	GnomAdGenome_AF_fin	NA	NA	het	175	1830.64	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	0.0896	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.3075	0.4446	0.307907	0.0	0.0364226	0.0		0.0					chr12	101759224	.	G	A	1830.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=1.4;AS_FS=0.557;AS_MQ=53.7;AS_MQRankSum=-2.5;AS_QD=10.46;AS_ReadPosRankSum=1.8;AS_SOR=0.775;BaseQRankSum=1.49;DP=178;ExcessHet=3.0103;FS=0.557;MLEAC=1;MLEAF=0.5;MQ=55.13;MQRankSum=-2.429;QD=10.46;ReadPosRankSum=1.89;SOR=0.775	GT:AD:DP:GQ:PL	0/1:94,81:175:99:1838,0,2063
chr12	101759363	101759364	AA	-	GNPTAB	intronic	.	.	.	0.0006	GnomAdGenome_AF_afr	NA	NA	het	43	170.6	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	0.0896	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.0002	0.0006	0.0	0.0	0.0	0.0		0.0					chr12	101759362	.	CAA	C	170.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-0.7;AS_FS=1.744;AS_MQ=60;AS_MQRankSum=0.8;AS_QD=3.91;AS_ReadPosRankSum=0.3;AS_SOR=1.402;BaseQRankSum=0.453;DP=90;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=59.09;MQRankSum=0.568;QD=7.42;ReadPosRankSum=0.477;SOR=0.906	GT:AD:DP:GQ:PL	0/1:14,9:43:99:178,0,926
chr12	101759420	101759420	A	-	GNPTAB	intronic	.	.	.	0.0223	GnomAdGenome_AF_afr	NA	NA	het	117	508.6	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	0.0896	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.0131	0.0223	0.0	0.0	9.06e-05	0.0		0.0					chr12	101759419	.	TA	T	508.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=0.8;AS_FS=1.809;AS_MQ=60;AS_MQRankSum=0;AS_QD=3.94;AS_ReadPosRankSum=0.4;AS_SOR=0.958;BaseQRankSum=0.152;DP=132;ExcessHet=3.0103;FS=3.553;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=5.78;ReadPosRankSum=-0.006;SOR=1.074	GT:AD:DP:GQ:PL	0/1:51,37:117:99:516,0,1085
chr12	101760782	101760782	T	-	GNPTAB	intronic	.	.	.	0.0074	GnomAdGenome_AF_fin	NA	NA	het	546	2714.6	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	0.0896	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.0014	0.0074	0.0	0.0	0.0001537	0.0		0.0					chr12	101760781	.	CT	C	2714.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=0.5;AS_FS=5.02;AS_MQ=59.13;AS_MQRankSum=-0.1;AS_QD=2.54;AS_ReadPosRankSum=-0.2;AS_SOR=0.961;BaseQRankSum=1.38;DP=717;ExcessHet=3.0103;FS=3.395;MLEAC=1;MLEAF=0.5;MQ=59.79;MQRankSum=-1.004;QD=6.77;ReadPosRankSum=-0.523;SOR=0.986	GT:AD:DP:GQ:PL	0/1:242,159:546:99:2722,0,4433
chr12	101761122	101761122	A	G	GNPTAB	intronic	.	.	.	0.9072	GnomAdGenome_AF_eas	325.0	63.0	het	1029	11465.6	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	Mucolipidosis_type_II|Pseudo-Hurler_polydystrophy|not_specified|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.0001	0.02	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	0.0896	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.5992	0.9053	0.9051	0.6106	0.9072	0.690495	0.5967	0.58637	0.596059	PASS	0.0	0.65	339.0	0.669014	64.0	chr12	101761122	.	A	G	11465.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-8.1;AS_FS=0;AS_MQ=60;AS_MQRankSum=0;AS_QD=11.14;AS_ReadPosRankSum=-3.3;AS_SOR=0.706;BaseQRankSum=-8.066;DP=1063;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.14;ReadPosRankSum=-3.211;SOR=0.706	GT:AD:DP:GQ:PL	0/1:480,549:1029:99:11473,0,11035
chr12	101762525	101762525	A	T	GNPTAB	intronic	.	.	.	0.9073	GnomAdGenome_AF_eas	NA	NA	het	906	9917.64	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	0.0896	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.6095	0.9073	0.689696	0.0	0.0001153	0.0		0.0					chr12	101762525	.	A	T	9917.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-3.5;AS_FS=0;AS_MQ=60;AS_MQRankSum=0;AS_QD=10.95;AS_ReadPosRankSum=0.1;AS_SOR=0.659;BaseQRankSum=-3.452;DP=941;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=10.95;ReadPosRankSum=0.138;SOR=0.659	GT:AD:DP:GQ:PL	0/1:456,450:906:99:9925,0,10491
chr12	101762904	101762904	A	-	GNPTAB	intronic	.	.	.	0.3193	GnomAdGenome_AF_eas	NA	NA	het	369	1262.6	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	0.0896	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.0249	0.3193	0.0	0.0	0.0001537	0.0		0.0					chr12	101762903	.	TA	T	1262.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-1.2;AS_FS=0;AS_MQ=58.48;AS_MQRankSum=0;AS_QD=0.35;AS_ReadPosRankSum=-0.4;AS_SOR=0.646;BaseQRankSum=-2.142;DP=578;ExcessHet=3.0103;FS=0.489;MLEAC=1;MLEAF=0.5;MQ=59.89;MQRankSum=0;QD=4.68;ReadPosRankSum=-1.354;SOR=0.762	GT:AD:DP:GQ:PL	0/1:190,80:369:99:1270,0,2046
chr12	101763222	101763222	A	-	GNPTAB	intronic	.	.	.	0.0168	GnomAdGenome_AF_afr	NA	NA	het	453	528.6	QD2	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	0.0896	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.0074	0.0168	0.0	0.0	0.000461	0.0		0.0					chr12	101763221	.	CA	C	528.6	QD2	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-0.1;AS_FS=2.351;AS_MQ=57.82;AS_MQRankSum=0.6;AS_QD=1.29;AS_ReadPosRankSum=0.7;AS_SOR=0.891;BaseQRankSum=-0.539;DP=561;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=59.84;MQRankSum=0.849;QD=1.29;ReadPosRankSum=1.86;SOR=0.694	GT:AD:DP:GQ:PL	0/1:341,70:453:99:536,0,11241
chr12	101763451	101763451	T	-	GNPTAB	intronic	.	.	.	0.003	GnomAdGenome_AF_afr	NA	NA	het	656	1807.6	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	0.0896	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.0012	0.003	0.0	0.0	8.41e-05	0.0		0.0					chr12	101763450	.	AT	A	1807.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-0.3;AS_FS=2.154;AS_MQ=60;AS_MQRankSum=0;AS_QD=3.04;AS_ReadPosRankSum=0.4;AS_SOR=0.814;BaseQRankSum=0.541;DP=753;ExcessHet=3.0103;FS=2.755;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=3.04;ReadPosRankSum=0.212;SOR=0.83	GT:AD:DP:GQ:PL	0/1:464,130:656:99:1815,0,11755
chr12	101763775	101763775	G	C	GNPTAB	intronic	.	.	.	0.4004	GnomAdGenome_AF_fin	NA	NA	het	983	11011.6	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	0.0896	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.2602	0.4004	0.244609	0.0	0.280198	0.0		0.0					chr12	101763775	.	G	C	11011.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-0.4;AS_FS=0.516;AS_MQ=60;AS_MQRankSum=0;AS_QD=11.2;AS_ReadPosRankSum=-0.3;AS_SOR=0.74;BaseQRankSum=-0.338;DP=1019;ExcessHet=3.0103;FS=0.516;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.2;ReadPosRankSum=-0.21;SOR=0.74	GT:AD:DP:GQ:PL	0/1:496,487:983:99:11019,0,11298
chr12	101764985	101764985	T	C	GNPTAB	exonic	synonymous SNV	.	GNPTAB:NM_024312:exon13:c.A1932G:p.T644T	0.9067	GnomAdGenome_AF_eas	347.0	63.0	het	912	10050.6	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	Benign	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	Mucolipidosis_type_II|Pseudo-Hurler_polydystrophy|not_specified|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	0.0896	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.5903	0.9046	0.9045	0.581	0.9067	0.651358	0.5625	0.0033053	0.565681	PASS	0.655172	0.641	376.0	0.669014	64.0	chr12	101764985	.	T	C	10050.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-5.4;AS_FS=4.004;AS_MQ=60;AS_MQRankSum=0;AS_QD=11.02;AS_ReadPosRankSum=-2.3;AS_SOR=0.627;BaseQRankSum=-5.353;DP=960;ExcessHet=3.0103;FS=4.004;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.02;ReadPosRankSum=-2.206;SOR=0.627	GT:AD:DP:GQ:PL	0/1:443,469:912:99:10058,0,10417
chr12	101767325	101767325	A	G	GNPTAB	intronic	.	.	.	0.5719	GnomAdGenome_AF_afr	NA	NA	het	927	11178.6	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	0.0896	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.4606	0.5719	0.465855	0.0	0.0697404	0.0		0.0					chr12	101767325	.	A	G	11178.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-1.5;AS_FS=0;AS_MQ=60;AS_MQRankSum=0;AS_QD=12.06;AS_ReadPosRankSum=1.7;AS_SOR=0.715;BaseQRankSum=-1.482;DP=951;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=12.06;ReadPosRankSum=1.74;SOR=0.715	GT:AD:DP:GQ:PL	0/1:437,490:927:99:11186,0,9702
chr12	101768326	101768326	C	T	GNPTAB	intronic	.	.	.	0.9056	GnomAdGenome_AF_eas	84.0	NA	het	648	7348.64	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	not_provided	criteria_provided,_single_submitter	Benign	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	0.0896	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.5812	0.9056	0.64996	0.0	0.564623	0.565506	PASS	0.0	0.601	40.0			chr12	101768326	.	C	T	7348.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-2;AS_FS=0;AS_MQ=60;AS_MQRankSum=0;AS_QD=11.34;AS_ReadPosRankSum=0;AS_SOR=0.706;BaseQRankSum=-1.904;DP=663;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.34;ReadPosRankSum=0.065;SOR=0.706	GT:AD:DP:GQ:PL	0/1:324,324:648:99:7356,0,7691
chr12	101768547	101768547	G	A	GNPTAB	intronic	.	.	.	0.5326	GnomAdGenome_AF_fin	NA	NA	het	651	6826.64	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	0.0896	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.4441	0.5326	0.439696	0.0	0.0686537	0.0		0.0					chr12	101768547	.	G	A	6826.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=1.6;AS_FS=0;AS_MQ=60;AS_MQRankSum=0;AS_QD=10.49;AS_ReadPosRankSum=-0.9;AS_SOR=0.692;BaseQRankSum=1.65;DP=672;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=10.49;ReadPosRankSum=-0.839;SOR=0.692	GT:AD:DP:GQ:PL	0/1:354,297:651:99:6834,0,8237
chr12	101769256	101769256	T	C	GNPTAB	intronic	.	.	.	0.907	GnomAdGenome_AF_eas	NA	NA	het	583	7236.64	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	0.0896	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.6098	0.907	0.689696	0.0	0.575995	0.0		0.0					chr12	101769256	.	T	C	7236.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=0.9;AS_FS=1.097;AS_MQ=60;AS_MQRankSum=0;AS_QD=12.41;AS_ReadPosRankSum=0.3;AS_SOR=0.61;BaseQRankSum=0.987;DP=592;ExcessHet=3.0103;FS=1.097;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=12.41;ReadPosRankSum=0.318;SOR=0.61	GT:AD:DP:GQ:PL	0/1:277,306:583:99:7244,0,6257
chr12	101771247	101771248	TT	-	GNPTAB	intronic	.	.	.	0.003	GnomAdGenome_AF_afr	NA	NA	het	306	1470.6	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	0.0896	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.0012	0.003	0.0	0.0	0.0	0.0		0.0					chr12	101771246	.	CTT	C	1470.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-1;AS_FS=2.083;AS_MQ=60;AS_MQRankSum=0;AS_QD=1.14;AS_ReadPosRankSum=1.4;AS_SOR=0.513;BaseQRankSum=-0.277;DP=404;ExcessHet=3.0103;FS=1.42;MLEAC=1;MLEAF=0.5;MQ=59.9;MQRankSum=0;QD=8.97;ReadPosRankSum=2.25;SOR=0.612	GT:AD:DP:GQ:PL	0/1:109,55:306:99:1478,0,4441
chr12	101771305	101771305	A	G	GNPTAB	intronic	.	.	.	0.9064	GnomAdGenome_AF_eas	44.0	31.0	het	369	3838.64	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	not_provided	criteria_provided,_single_submitter	Benign	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	0.0896	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.6133	0.9064	0.69389	0.0	0.0001921	0.605263	PASS	0.0	0.465	18.0	0.570312	11.0	chr12	101771305	.	A	G	3838.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-1.3;AS_FS=2.211;AS_MQ=59.96;AS_MQRankSum=-1;AS_QD=10.4;AS_ReadPosRankSum=-0.7;AS_SOR=0.825;BaseQRankSum=-1.254;DP=384;ExcessHet=3.0103;FS=2.211;MLEAC=1;MLEAF=0.5;MQ=59.94;MQRankSum=-0.95;QD=10.4;ReadPosRankSum=-0.652;SOR=0.825	GT:AD:DP:GQ:PL	0/1:176,193:369:99:3846,0,3523
chr12	101771564	101771564	G	A	GNPTAB	intronic	.	.	.	0.3999	GnomAdGenome_AF_fin	NA	NA	het	649	6949.64	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	0.0896	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.2429	0.3999	0.223842	0.0	0.274358	0.0		0.0					chr12	101771564	.	G	A	6949.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=2.3;AS_FS=1.728;AS_MQ=60;AS_MQRankSum=1.3;AS_QD=10.71;AS_ReadPosRankSum=-1.2;AS_SOR=0.792;BaseQRankSum=2.32;DP=664;ExcessHet=3.0103;FS=1.728;MLEAC=1;MLEAF=0.5;MQ=59.97;MQRankSum=1.34;QD=10.71;ReadPosRankSum=-1.112;SOR=0.792	GT:AD:DP:GQ:PL	0/1:343,306:649:99:6957,0,7774
chr12	101771646	101771646	A	G	GNPTAB	intronic	.	.	.	0.0598	GnomAdGenome_AF_sas	NA	NA	het	683	8188.64	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	0.0896	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.0381	0.0598	0.0231629	0.0	0.0445674	0.0		0.0					chr12	101771646	.	A	G	8188.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=0.1;AS_FS=0.521;AS_MQ=60;AS_MQRankSum=0;AS_QD=11.99;AS_ReadPosRankSum=-1.9;AS_SOR=0.768;BaseQRankSum=0.147;DP=702;ExcessHet=3.0103;FS=0.521;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.99;ReadPosRankSum=-1.853;SOR=0.768	GT:AD:DP:GQ:PL	0/1:332,351:683:99:8196,0,7665
chr12	101778905	101778905	A	-	GNPTAB	intronic	.	.	.	0.0016	GnomAdGenome_AF_fin	NA	NA	het	181	1011.6	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	0.0896	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.0004	0.0016	0.0	0.0	0.0002305	0.0		0.0					chr12	101778904	.	CA	C	1011.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-1.4;AS_FS=1.315;AS_MQ=60;AS_MQRankSum=0;AS_QD=6.17;AS_ReadPosRankSum=-0.5;AS_SOR=0.81;BaseQRankSum=-1.08;DP=212;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=6.17;ReadPosRankSum=-0.86;SOR=0.673	GT:AD:DP:GQ:PL	0/1:110,54:181:99:1019,0,2710
chr12	101778917	101778917	C	T	GNPTAB	intronic	.	.	.	0.9115	GnomAdGenome_AF_eas	NA	NA	het	198	237.64	QD2	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	0.0896	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.6346	0.9115	0.718251	0.0	0.0003074	0.0		0.0					chr12	101778917	.	C	T	237.64	QD2	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=0.7;AS_FS=0;AS_MQ=60;AS_MQRankSum=0;AS_QD=1.2;AS_ReadPosRankSum=0.1;AS_SOR=0.635;BaseQRankSum=0.735;DP=202;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=1.2;ReadPosRankSum=0.108;SOR=0.635	GT:AD:DP:GQ:PL	0/1:171,27:198:99:245,0,4465
chr12	101779876	101779876	T	C	GNPTAB	intronic	.	.	.	0.9237	GnomAdGenome_AF_eas	NA	NA	het	195	424.64	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	not_provided	criteria_provided,_single_submitter	Benign	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	0.0896	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.6405	0.9237	0.727436	0.0	0.0994748	0.627796	PASS	0.0					chr12	101779876	.	T	C	424.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-1.6;AS_FS=2.331;AS_MQ=60;AS_MQRankSum=0;AS_QD=2.18;AS_ReadPosRankSum=0.1;AS_SOR=0.953;BaseQRankSum=-1.534;DP=201;ExcessHet=3.0103;FS=2.331;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=2.18;ReadPosRankSum=0.118;SOR=0.953	GT:AD:DP:GQ:PL	0/1:158,37:195:99:432,0,4076
chr12	101786142	101786142	G	-	GNPTAB	exonic	frameshift deletion	.	GNPTAB:NM_024312:exon5:c.441delC:p.N148Tfs*4	0.0003	GnomAdGenome_AF_sas	0.0	NA	het	598	9356.6	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	Mucolipidosis_type_II|Pseudo-Hurler_polydystrophy	criteria_provided,_multiple_submitters,_no_conflicts	Pathogenic/Likely_pathogenic	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	0.0896	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	7.962e-06	6.536e-05	6.375e-05	6.979e-06	0.0003	0.0	0.0	6.5e-06	0.0		0.0	0.0005988	1.0			chr12	101786141	.	TG	T	9356.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-0.1;AS_FS=0;AS_MQ=60;AS_MQRankSum=0;AS_QD=15.65;AS_ReadPosRankSum=-0.8;AS_SOR=0.719;BaseQRankSum=-0.055;DP=622;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.65;ReadPosRankSum=-0.77;SOR=0.719	GT:AD:DP:GQ:PL	0/1:297,301:598:99:9364,0,9199
chr12	101786450	101786450	C	T	GNPTAB	intronic	.	.	.	0.9241	GnomAdGenome_AF_eas	58.0	NA	het	571	6707.64	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	not_provided	criteria_provided,_single_submitter	Benign	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	0.0896	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.6728	0.9241	0.749002	0.0	0.0001153	0.624542	PASS	0.0	0.539	21.0			chr12	101786450	.	C	T	6707.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=1.9;AS_FS=0.521;AS_MQ=60;AS_MQRankSum=0;AS_QD=11.81;AS_ReadPosRankSum=1.4;AS_SOR=0.64;BaseQRankSum=1.98;DP=618;ExcessHet=3.0103;FS=0.521;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.81;ReadPosRankSum=1.31;SOR=0.62	GT:AD:DP:GQ:PL	0/1:286,282:571:99:6715,0,6637
chr12	101787913	101787913	-	A	GNPTAB	intronic	.	.	.	0.8168	GnomAdGenome_AF_amr	NA	NA	het	162	646.6	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	0.0896	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.7061	0.8168	0.701877	0.0	0.0004226	0.0		0.0					chr12	101787913	.	C	CA	646.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-0.4;AS_FS=3.48;AS_MQ=60;AS_MQRankSum=2;AS_QD=2.95;AS_ReadPosRankSum=1.5;AS_SOR=1.129;BaseQRankSum=0.267;DP=276;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=58.64;MQRankSum=2.58;QD=6.6;ReadPosRankSum=1.76;SOR=0.668	GT:AD:DP:GQ:PL	0/1:59,39:162:99:654,0,1302
chr12	101788264	101788264	C	T	GNPTAB	intronic	.	.	.	0.1882	GnomAdGenome_AF_fin	0.0	NA	het	493	5997.64	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	not_provided	criteria_provided,_single_submitter	Benign	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	0.0896	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.0808	0.1882	0.0694888	0.0	0.0890579	0.066445	PASS	0.0	0.011	2.0			chr12	101788264	.	C	T	5997.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=4.1;AS_FS=1.742;AS_MQ=60;AS_MQRankSum=0;AS_QD=12.22;AS_ReadPosRankSum=0.9;AS_SOR=0.876;BaseQRankSum=4.09;DP=526;ExcessHet=3.0103;FS=2.447;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=12.22;ReadPosRankSum=0.915;SOR=0.875	GT:AD:DP:GQ:PL	0/1:244,247:493:99:6005,0,5382
chr12	101788403	101788403	G	A	GNPTAB	intronic	.	.	.	0.9236	GnomAdGenome_AF_eas	66.0	65.0	het	525	5970.64	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	Mucolipidosis_type_II|Pseudo-Hurler_polydystrophy|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	0.0896	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.6025	0.9236	0.684305	0.0	0.106693	0.57743	PASS	0.0	0.53	44.0	0.656028	55.0	chr12	101788403	.	G	A	5970.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=3.1;AS_FS=1.092;AS_MQ=60;AS_MQRankSum=0;AS_QD=11.37;AS_ReadPosRankSum=0.1;AS_SOR=0.769;BaseQRankSum=3.11;DP=552;ExcessHet=3.0103;FS=1.092;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.37;ReadPosRankSum=0.122;SOR=0.769	GT:AD:DP:GQ:PL	0/1:275,250:525:99:5978,0,6249
chr12	101788451	101788452	AC	-	GNPTAB	intronic	.	.	.	0.4431	GnomAdGenome_AF_fin	5.0	8.0	het	514	9182.6	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	not_provided	criteria_provided,_single_submitter	Benign	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	0.0896	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.3298	0.4431	0.334864	0.0	0.0555556	0.294745	PASS	0.0	0.179	65.0	0.204225	42.0	chr12	101788450	.	AAC	A	9182.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=1.1;AS_FS=0.521;AS_MQ=60;AS_MQRankSum=0;AS_QD=17.87;AS_ReadPosRankSum=2.2;AS_SOR=0.759;BaseQRankSum=1.11;DP=558;ExcessHet=3.0103;FS=0.521;MLEAC=1;MLEAF=0.5;MQ=59.98;MQRankSum=0;QD=17.86;ReadPosRankSum=2.29;SOR=0.759	GT:AD:DP:GQ:PL	0/1:266,248:514:99:9190,0,9884
chr12	101788929	101788929	A	T	GNPTAB	intronic	.	.	.	0.9236	GnomAdGenome_AF_eas	NA	NA	het	556	6767.64	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	0.0896	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.6205	0.9236	0.707468	0.0	0.0960078	0.0		0.0					chr12	101788929	.	A	T	6767.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-1.1;AS_FS=1.736;AS_MQ=60;AS_MQRankSum=0;AS_QD=12.17;AS_ReadPosRankSum=-0.1;AS_SOR=0.569;BaseQRankSum=-1.029;DP=568;ExcessHet=3.0103;FS=1.736;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=12.17;ReadPosRankSum=-0.005;SOR=0.569	GT:AD:DP:GQ:PL	0/1:265,291:556:99:6775,0,6131
chr12	101789046	101789046	T	C	GNPTAB	intronic	.	.	.	0.4007	GnomAdGenome_AF_fin	NA	NA	het	584	6325.64	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	0.0896	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.2835	0.4007	0.274361	0.0	0.290879	0.0		0.0					chr12	101789046	.	T	C	6325.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-1.1;AS_FS=1.102;AS_MQ=60;AS_MQRankSum=0;AS_QD=10.83;AS_ReadPosRankSum=-0.8;AS_SOR=0.697;BaseQRankSum=-1.088;DP=601;ExcessHet=3.0103;FS=1.102;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=10.83;ReadPosRankSum=-0.724;SOR=0.697	GT:AD:DP:GQ:PL	0/1:309,275:584:99:6333,0,7327
chr12	101790293	101790293	C	T	GNPTAB	intronic	.	.	.	0.9994	GnomAdGenome_AF_eas	113.0	NA	hom	565	16454.1	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	not_provided	criteria_provided,_single_submitter	Benign	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	0.0896	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.9716	0.9994	0.982428	0.0	0.161395	0.978261	PASS	0.0	0.942	2.0			chr12	101790293	.	C	T	16454.1	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=29.17;AS_ReadPosRankSum=.;AS_SOR=0.946;DP=574;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.17;SOR=0.95	GT:AD:DP:GQ:PL	1/1:0,564:565:99:16468,1690,0
chr12	101796904	101796904	-	ATCGTGACTGGC	GNPTAB	intronic	.	.	.	0.0	GnomAdExome_AF	NA	NA	het	336	8327.6	FS200	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	0.0896	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0					chr12	101796904	.	A	AATCGTGACTGGC	8327.6	FS200	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=10.3;AS_FS=579.317;AS_MQ=60;AS_MQRankSum=0;AS_QD=24.79;AS_ReadPosRankSum=4;AS_SOR=10.704;BaseQRankSum=10.37;DP=391;ExcessHet=3.0103;FS=579.317;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=24.78;ReadPosRankSum=4;SOR=10.704	GT:AD:DP:GQ:PGT:PID:PL:PS	0|1:126,210:336:99:0|1:101796904_A_AATCGTGACTGGC:8335,0,3782:101796904
chr12	101796906	101796906	A	G	GNPTAB	intronic	.	.	.	1.549e-05	GnomAdGenome_AF_nfe	NA	NA	het	335	8331.64	FS60;ReadPosRankSum-8;SOR3	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	0.0896	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	6.977e-06	1.549e-05	0.0	0.0	0.0	0.0		0.0					chr12	101796906	.	A	G	8331.64	FS60;ReadPosRankSum-8;SOR3	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=11.2;AS_FS=575.057;AS_MQ=60;AS_MQRankSum=0;AS_QD=24.87;AS_ReadPosRankSum=-13.2;AS_SOR=10.704;BaseQRankSum=11.28;DP=380;ExcessHet=3.0103;FS=575.057;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=24.87;ReadPosRankSum=-13.16;SOR=10.704	GT:AD:DP:GQ:PGT:PID:PL:PS	0|1:125,210:335:99:0|1:101796904_A_AATCGTGACTGGC:8339,0,3746:101796904
chr12	101830496	101830496	G	T	GNPTAB	intronic	.	.	.	0.0	GnomAdExome_AF	NA	NA	het	107	103.64	QD2	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	0.0896	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0					chr12	101830496	.	G	T	103.64	QD2	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=3.4;AS_FS=2.711;AS_MQ=60;AS_MQRankSum=0;AS_QD=0.97;AS_ReadPosRankSum=-0.1;AS_SOR=1.25;BaseQRankSum=3.42;DP=111;ExcessHet=3.0103;FS=2.711;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=0.97;ReadPosRankSum=-0.034;SOR=1.25	GT:AD:DP:GQ:PL	0/1:94,13:107:99:111,0,2262
chr12	101830714	101830716	GCC	-	GNPTAB	UTR5	.	NM_024312:c.-39_-41delGGC	.	0.849	GnomAdGenome_AF_eas	202.0	66.0	het	69	1486.6	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	Mucolipidosis_type_II|Pseudo-Hurler_polydystrophy|not_specified|Mucolipidosis,_Type_III_Alpha/Beta|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	0.0896	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.5452	0.8381	0.8396	0.6284	0.849	0.702276	0.2328	0.0001153	0.614498	PASS	0.0	0.628	242.0	0.683099	62.0	chr12	101830713	.	AGCC	A	1486.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=1;AS_FS=0;AS_MQ=60;AS_MQRankSum=0;AS_QD=21.55;AS_ReadPosRankSum=0.1;AS_SOR=0.622;BaseQRankSum=1.01;DP=86;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=21.54;ReadPosRankSum=0.158;SOR=0.622	GT:AD:DP:GQ:PL	0/1:31,38:69:99:1494,0,1171
chr16	88813579	88813579	G	C	GALNS	downstream	.	dist=155	.	0.5333	GnomAdGenome_AF_eas	NA	NA	hom	189	5584.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.2291	0.5333	0.277356	0.0	0.0001153	0.349442	PASS	0.0					chr16	88813579	.	G	C	5584.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=29.54;AS_ReadPosRankSum=.;AS_SOR=1.221;DP=191;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.55;SOR=1.221	GT:AD:DP:GQ:PL	1/1:0,189:189:99:5598,561,0
chr16	88813738	88813738	G	C	GALNS	UTR3	.	NM_001323543:c.*701C>G;NM_000512:c.*701C>G;NM_001323544:c.*701C>G	.	0.5324	GnomAdGenome_AF_eas	14.0	1.0	hom	177	5200.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	Mucopolysaccharidosis,_MPS-IV-A|Adenine_phosphoribosyltransferase_deficiency|Morquio_syndrome	criteria_provided,_single_submitter	Benign	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.2162	0.5324	0.261182	0.0	0.253035	0.251429	PASS	0.0	0.204	50.0	0.15625	3.0	chr16	88813738	.	G	C	5200.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=29.38;AS_ReadPosRankSum=.;AS_SOR=0.902;DP=185;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.38;SOR=0.902	GT:AD:DP:GQ:PL	1/1:0,177:177:99:5214,530,0
chr16	88813787	88813787	T	C	GALNS	UTR3	.	NM_001323543:c.*652A>G;NM_000512:c.*652A>G;NM_001323544:c.*652A>G	.	0.532	GnomAdGenome_AF_eas	1.0	1.0	hom	189	5687.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	Mucopolysaccharidosis,_MPS-IV-A|Adenine_phosphoribosyltransferase_deficiency|Morquio_syndrome	criteria_provided,_single_submitter	Benign	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.2315	0.532	0.280351	0.0	0.0436411	0.292035	PASS	0.0	0.224	11.0	0.15625	3.0	chr16	88813787	.	T	C	5687.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=29.96;AS_ReadPosRankSum=.;AS_SOR=0.941;DP=195;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=30.41;SOR=0.938	GT:AD:DP:GQ:PL	1/1:0,187:189:99:5701,559,0
chr16	88813828	88813828	T	C	GALNS	UTR3	.	NM_001323543:c.*611A>G;NM_000512:c.*611A>G;NM_001323544:c.*611A>G	.	0.5332	GnomAdGenome_AF_eas	1.0	1.0	hom	197	5805.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	Mucopolysaccharidosis,_MPS-IV-A|Adenine_phosphoribosyltransferase_deficiency|Morquio_syndrome	criteria_provided,_single_submitter	Benign	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.2619	0.5332	0.314097	0.0	0.0452129	0.304762	PASS	0.0	0.224	11.0	0.15625	3.0	chr16	88813828	.	T	C	5805.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=29.47;AS_ReadPosRankSum=.;AS_SOR=0.856;DP=207;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.47;SOR=0.856	GT:AD:DP:GQ:PL	1/1:0,197:197:99:5819,587,0
chr16	88814072	88814072	A	G	GALNS	UTR3	.	NM_001323543:c.*367T>C;NM_000512:c.*367T>C;NM_001323544:c.*367T>C	.	0.6118	GnomAdGenome_AF_eas	NA	NA	hom	208	5625.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	Mucopolysaccharidosis,_MPS-IV-A|Adenine_phosphoribosyltransferase_deficiency|Morquio_syndrome|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	Benign	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.3313	0.6118	0.38778	0.0	0.337675	0.316964	PASS	0.0					chr16	88814072	.	A	G	5625.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=27.04;AS_ReadPosRankSum=.;AS_SOR=0.902;DP=213;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=27.04;SOR=0.902	GT:AD:DP:GQ:PL	1/1:0,208:208:99:5639,620,0
chr16	88814403	88814403	C	T	GALNS	UTR3	.	NM_001323543:c.*36G>A;NM_000512:c.*36G>A;NM_001323544:c.*36G>A	.	0.5511	GnomAdGenome_AF_eas	47.0	10.0	hom	197	5863.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	Mucopolysaccharidosis,_MPS-IV-A|Adenine_phosphoribosyltransferase_deficiency|Morquio_syndrome|not_specified|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	Benign	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.281	0.5484	0.5534	0.2382	0.5511	0.285743	0.2139	0.153665	0.269167	PASS	0.0	0.231	244.0	0.25	51.0	chr16	88814403	.	C	T	5863.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=29.76;AS_ReadPosRankSum=.;AS_SOR=0.724;DP=207;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.76;SOR=0.724	GT:AD:DP:GQ:PL	1/1:0,197:197:99:5877,587,0
chr16	88814557	88814557	C	G	GALNS	intronic	.	.	.	0.5313	GnomAdGenome_AF_eas	48.0	9.0	hom	232	6704.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	Mucopolysaccharidosis,_MPS-IV-A|not_specified|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	Benign	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.2501	0.5285	0.5347	0.1983	0.5313	0.251597	0.167	0.113032	0.233668	PASS	0.0	0.218	266.0	0.235915	49.0	chr16	88814557	.	C	G	6704.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=28.9;AS_ReadPosRankSum=.;AS_SOR=0.746;DP=237;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.9;SOR=0.746	GT:AD:DP:GQ:PL	1/1:0,232:232:99:6718,694,0
chr16	88814821	88814821	G	A	GALNS	intronic	.	.	.	0.0259	GnomAdGenome_AF_asj	NA	NA	hom	202	5659.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0012	0.0259	0.000199681	0.0	0.0009605	0.0		0.0					chr16	88814821	.	G	A	5659.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=28.01;AS_ReadPosRankSum=.;AS_SOR=0.754;DP=210;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=59.88;QD=28.02;SOR=0.754	GT:AD:DP:GQ:PL	1/1:0,202:202:99:5673,603,0
chr16	88815075	88815075	-	T	GALNS	intronic	.	.	.	0.9725	GnomAdGenome_AF_afr	5.0	NA	hom	109	4321.03	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.8898	0.9725	0.918331	0.0	0.0274704	0.0		0.0	0.218	0.0			chr16	88815075	.	C	CT	4321.03	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=29.37;AS_ReadPosRankSum=.;AS_SOR=0.749;DP=117;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=31.18;SOR=0.749	GT:AD:DP:GQ:PL	1/1:0,109:109:99:4335,328,0
chr16	88815227	88815227	T	C	GALNS	intronic	.	.	.	0.9456	GnomAdGenome_AF_ami	5.0	NA	hom	142	3914.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.8649	0.9456	0.888778	0.0	0.85919	0.0		0.0	0.917	1.0			chr16	88815227	.	T	C	3914.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=27.56;AS_ReadPosRankSum=.;AS_SOR=0.874;DP=145;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=27.56;SOR=0.874	GT:AD:DP:GQ:PL	1/1:0,142:142:99:3928,424,0
chr16	88816639	88816639	T	G	GALNS	intronic	.	.	.	0.6665	GnomAdGenome_AF_eas	2.0	NA	hom	110	3184.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.4465	0.6665	0.522764	0.0	0.0131397	0.0		0.0	0.5	1.0			chr16	88816639	.	T	G	3184.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=28.95;AS_ReadPosRankSum=.;AS_SOR=0.931;DP=117;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.95;SOR=0.931	GT:AD:DP:GQ:PL	1/1:0,110:110:99:3198,328,0
chr16	88817249	88817251	GAC	-	GALNS	intronic	.	.	.	0.7111	GnomAdGenome_AF_eas	2.0	NA	hom	174	7719.03	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.4372	0.7111	0.525958	0.0	0.0002305	0.0		0.0	0.5	1.0			chr16	88817248	.	AGAC	A	7719.03	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=28.88;AS_ReadPosRankSum=.;AS_SOR=0.865;DP=188;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=27.31;SOR=0.865	GT:AD:DP:GQ:PL	1/1:0,174:174:99:7733,524,0
chr16	88818058	88818058	C	T	GALNS	exonic	synonymous SNV	.	GALNS:NM_001323543:exon12:c.G876A:p.E292E,GALNS:NM_000512:exon13:c.G1431A:p.E477E,GALNS:NM_001323544:exon14:c.G1449A:p.E483E	0.6403	GnomAdExome_AF_eas	158.0	36.0	hom	159	4668.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	Benign	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	Mucopolysaccharidosis,_MPS-IV-A|not_specified|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	Benign	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.4071	0.6403	0.6403	0.4079	0.6378	0.474241	0.3991	0.0108729	0.438119	PASS	0.559172	0.424	392.0	0.457746	58.0	chr16	88818058	.	C	T	4668.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=29.36;AS_ReadPosRankSum=.;AS_SOR=0.839;DP=168;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.36;SOR=0.839	GT:AD:DP:GQ:PL	1/1:0,159:159:99:4682,475,0
chr16	88818401	88818401	A	G	GALNS	intronic	.	.	.	0.6263	GnomAdGenome_AF_eas	27.0	NA	hom	153	6727.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	not_provided	criteria_provided,_single_submitter	Benign	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.4095	0.6263	0.478035	0.0	0.0002305	0.43932	PASS	0.0	0.286	21.0			chr16	88818401	.	A	G	6727.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=27.77;AS_ReadPosRankSum=.;AS_SOR=0.788;DP=158;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=32.41;SOR=0.788	GT:AD:DP:GQ:PGT:PID:PL:PS	1|1:0,153:153:99:1|1:88818401_A_G:6741,460,0:88818401
chr16	88818405	88818405	T	C	GALNS	intronic	.	.	.	0.626	GnomAdGenome_AF_eas	27.0	NA	hom	153	6750.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	not_provided	criteria_provided,_single_submitter	Benign	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.4095	0.626	0.478035	0.0	0.319733	0.425693	PASS	0.0	0.282	21.0			chr16	88818405	.	T	C	6750.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=29.5;AS_ReadPosRankSum=.;AS_SOR=0.816;DP=153;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.74;SOR=0.816	GT:AD:DP:GQ:PGT:PID:PL:PS	1|1:0,153:153:99:1|1:88818401_A_G:6764,460,0:88818401
chr16	88818409	88818409	C	T	GALNS	intronic	.	.	.	0.6265	GnomAdGenome_AF_eas	27.0	NA	hom	149	6654.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	not_provided	criteria_provided,_single_submitter	Benign	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.4094	0.6265	0.478035	0.0	0.317312	0.425831	PASS	0.0	0.285	20.0			chr16	88818409	.	C	T	6654.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=27.43;AS_ReadPosRankSum=.;AS_SOR=0.82;DP=149;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=32.7;SOR=0.82	GT:AD:DP:GQ:PGT:PID:PL:PS	1|1:0,149:149:99:1|1:88818401_A_G:6668,449,0:88818401
chr16	88818501	88818501	C	G	GALNS	intronic	.	.	.	0.6412	GnomAdGenome_AF_eas	NA	NA	hom	163	4885.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.3744	0.6412	0.441294	0.0	0.384279	0.0		0.0					chr16	88818501	.	C	G	4885.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=29.97;AS_ReadPosRankSum=.;AS_SOR=0.782;DP=167;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.97;SOR=0.782	GT:AD:DP:GQ:PL	1/1:0,163:163:99:4899,488,0
chr16	88818592	88818592	A	G	GALNS	intronic	.	.	.	0.5843	GnomAdGenome_AF_eas	NA	NA	hom	147	4377.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.3117	0.5843	0.374201	0.0	0.327801	0.0		0.0					chr16	88818592	.	A	G	4377.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=29.78;AS_ReadPosRankSum=.;AS_SOR=0.792;DP=148;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.78;SOR=0.792	GT:AD:DP:GQ:PL	1/1:0,147:147:99:4391,440,0
chr16	88818672	88818672	C	T	GALNS	intronic	.	.	.	0.5851	GnomAdGenome_AF_eas	NA	NA	hom	141	4302.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.3007	0.5851	0.359425	0.0	0.322537	0.0		0.0					chr16	88818672	.	C	T	4302.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=30.51;AS_ReadPosRankSum=.;AS_SOR=0.766;DP=147;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=30.51;SOR=0.766	GT:AD:DP:GQ:PL	1/1:0,141:141:99:4316,421,0
chr16	88818724	88818724	T	C	GALNS	intronic	.	.	.	0.6399	GnomAdGenome_AF_eas	NA	NA	hom	163	4646.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.4141	0.6399	0.481829	0.0	0.39688	0.0		0.0					chr16	88818724	.	T	C	4646.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=28.5;AS_ReadPosRankSum=.;AS_SOR=0.892;DP=165;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.5;SOR=0.892	GT:AD:DP:GQ:PL	1/1:0,163:163:99:4660,488,0
chr16	88818928	88818928	G	A	GALNS	intronic	.	.	.	0.5857	GnomAdGenome_AF_eas	NA	NA	hom	163	3639.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.3114	0.5857	0.373003	0.0	0.304249	0.0		0.0					chr16	88818928	.	G	A	3639.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=23.39;AS_ReadPosRankSum=.;AS_SOR=0.92;DP=170;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=23.63;SOR=0.808	GT:AD:DP:GQ:PL	1/1:0,154:163:99:3653,443,0
chr16	88819017	88819017	C	A	GALNS	intronic	.	.	.	0.5854	GnomAdGenome_AF_eas	NA	NA	hom	159	4542.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.346	0.5854	0.40635	0.0	0.33683	0.0		0.0					chr16	88819017	.	C	A	4542.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=1.8;AS_FS=0;AS_MQ=60;AS_MQRankSum=0;AS_QD=28.57;AS_ReadPosRankSum=1.7;AS_SOR=0.291;BaseQRankSum=1.85;DP=162;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=28.57;ReadPosRankSum=1.73;SOR=0.291	GT:AD:DP:GQ:PL	1/1:1,158:159:99:4556,464,0
chr16	88819148	88819148	C	T	GALNS	intronic	.	.	.	0.5846	GnomAdGenome_AF_eas	NA	NA	hom	161	4548.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.3465	0.5846	0.40595	0.0	0.337329	0.0		0.0					chr16	88819148	.	C	T	4548.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=28.25;AS_ReadPosRankSum=.;AS_SOR=0.866;DP=170;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.25;SOR=0.866	GT:AD:DP:GQ:PL	1/1:0,161:161:99:4562,478,0
chr16	88819530	88819530	-	TCT	GALNS	intronic	.	.	.	0.6366	GnomAdGenome_AF_eas	NA	NA	hom	140	6261.03	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.4138	0.6366	0.481829	0.0	0.0001153	0.0		0.0					chr16	88819530	.	A	ATCT	6261.03	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=31.1;AS_ReadPosRankSum=.;AS_SOR=0.751;DP=149;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=26.83;SOR=0.751	GT:AD:DP:GQ:PL	1/1:0,140:140:99:6275,421,0
chr16	88819971	88819971	T	C	GALNS	intronic	.	.	.	0.6426	GnomAdGenome_AF_eas	NA	NA	hom	152	4116.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.4174	0.6426	0.481629	0.0	0.392923	0.0		0.0					chr16	88819971	.	T	C	4116.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=59.58;AS_MQRankSum=.;AS_QD=27.08;AS_ReadPosRankSum=.;AS_SOR=0.988;DP=155;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=59.59;QD=27.08;SOR=0.988	GT:AD:DP:GQ:PL	1/1:0,152:152:99:4130,453,0
chr16	88820240	88820240	C	T	GALNS	intronic	.	.	.	0.7134	GnomAdGenome_AF_eas	NA	NA	hom	185	5210.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.4467	0.7134	0.530152	0.0	0.413516	0.0		0.0					chr16	88820240	.	C	T	5210.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=59.96;AS_MQRankSum=.;AS_QD=28.16;AS_ReadPosRankSum=.;AS_SOR=0.918;DP=188;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=59.96;QD=28.16;SOR=0.918	GT:AD:DP:GQ:PL	1/1:0,185:185:99:5224,551,0
chr16	88820987	88820987	C	T	GALNS	intronic	.	.	.	0.6012	GnomAdGenome_AF_eas	NA	NA	hom	143	3962.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.3679	0.6012	0.427117	0.0	0.335216	0.0		0.0					chr16	88820987	.	C	T	3962.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=27.71;AS_ReadPosRankSum=.;AS_SOR=0.991;DP=150;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=27.71;SOR=0.991	GT:AD:DP:GQ:PL	1/1:0,143:143:99:3976,426,0
chr16	88821030	88821030	G	A	GALNS	intronic	.	.	.	0.6169	GnomAdGenome_AF_eas	NA	NA	hom	149	6043.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.3678	0.6169	0.4377	0.0	0.343515	0.0		0.0					chr16	88821030	.	G	A	6043.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=24.71;AS_ReadPosRankSum=.;AS_SOR=1.012;DP=154;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=25.57;SOR=1.012	GT:AD:DP:GQ:PGT:PID:PL:PS	1|1:0,149:149:99:1|1:88821030_G_A:6057,447,0:88821030
chr16	88821051	88821051	C	T	GALNS	intronic	.	.	.	0.6182	GnomAdGenome_AF_eas	NA	NA	hom	150	6121.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.33	0.6182	0.397165	0.0	0.343822	0.0		0.0					chr16	88821051	.	C	T	6121.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=34.44;AS_ReadPosRankSum=.;AS_SOR=0.927;DP=152;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=33.12;SOR=0.927	GT:AD:DP:GQ:PGT:PID:PL:PS	1|1:0,150:150:99:1|1:88821030_G_A:6135,451,0:88821030
chr16	88821086	88821086	C	A	GALNS	intronic	.	.	.	0.6182	GnomAdGenome_AF_eas	NA	NA	hom	135	3701.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.3918	0.6182	0.457668	0.0	0.370985	0.0		0.0					chr16	88821086	.	C	A	3701.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=1.7;AS_FS=0;AS_MQ=60;AS_MQRankSum=0;AS_QD=27.41;AS_ReadPosRankSum=1.1;AS_SOR=0.248;BaseQRankSum=1.77;DP=144;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=27.42;ReadPosRankSum=1.18;SOR=0.248	GT:AD:DP:GQ:PL	1/1:1,134:135:99:3715,389,0
chr16	88821146	88821146	A	G	GALNS	intronic	.	.	.	0.6412	GnomAdGenome_AF_eas	NA	NA	hom	134	3918.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.4042	0.6412	0.468251	0.0	0.290533	0.0		0.0					chr16	88821146	.	A	G	3918.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=29.24;AS_ReadPosRankSum=.;AS_SOR=0.785;DP=141;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.24;SOR=0.785	GT:AD:DP:GQ:PL	1/1:0,134:134:99:3932,400,0
chr16	88821173	88821179	CCAGAGG	-	GALNS	intronic	.	.	.	0.6022	GnomAdGenome_AF_eas	NA	NA	hom	115	5149.03	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.3567	0.6022	0.41274	0.0	0.059436	0.0		0.0					chr16	88821172	.	TCCAGAGG	T	5149.03	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=29.54;AS_ReadPosRankSum=.;AS_SOR=1.074;DP=131;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=31.29;SOR=1.074	GT:AD:DP:GQ:PL	1/1:0,115:115:99:5163,347,0
chr16	88821275	88821275	G	C	GALNS	intronic	.	.	.	0.6404	GnomAdGenome_AF_eas	NA	NA	hom	144	4125.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.3273	0.6404	0.390375	0.0	0.368795	0.0		0.0					chr16	88821275	.	G	C	4125.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=28.65;AS_ReadPosRankSum=.;AS_SOR=0.749;DP=152;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.65;SOR=0.749	GT:AD:DP:GQ:PL	1/1:0,144:144:99:4139,428,0
chr16	88821375	88821375	C	G	GALNS	intronic	.	.	.	0.525	GnomAdGenome_AF_eas	NA	NA	hom	167	4701.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.2206	0.525	0.271765	0.0	0.258107	0.0		0.0					chr16	88821375	.	C	G	4701.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=28.15;AS_ReadPosRankSum=.;AS_SOR=0.705;DP=172;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.15;SOR=0.705	GT:AD:DP:GQ:PL	1/1:0,167:167:99:4715,495,0
chr16	88821660	88821660	C	G	GALNS	intronic	.	.	.	0.6399	GnomAdGenome_AF_eas	NA	NA	hom	164	4426.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.4145	0.6399	0.482029	0.0	0.394844	0.0		0.0					chr16	88821660	.	C	G	4426.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=26.99;AS_ReadPosRankSum=.;AS_SOR=1.124;DP=168;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=26.99;SOR=1.124	GT:AD:DP:GQ:PL	1/1:0,164:164:99:4440,486,0
chr16	88821923	88821923	A	G	GALNS	intronic	.	.	.	0.5854	GnomAdGenome_AF_eas	NA	NA	hom	139	3808.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.2989	0.5854	0.351438	0.0	0.0001153	0.0		0.0					chr16	88821923	.	A	G	3808.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=27.4;AS_ReadPosRankSum=.;AS_SOR=0.929;DP=145;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=27.4;SOR=0.929	GT:AD:DP:GQ:PL	1/1:0,139:139:99:3822,412,0
chr16	88821947	88821947	G	T	GALNS	intronic	.	.	.	0.5846	GnomAdGenome_AF_eas	NA	NA	hom	135	3563.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.3467	0.5846	0.40655	0.0	0.0001153	0.0		0.0					chr16	88821947	.	G	T	3563.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=2.5;AS_FS=2.956;AS_MQ=60;AS_MQRankSum=0;AS_QD=26.39;AS_ReadPosRankSum=-0.6;AS_SOR=0.169;BaseQRankSum=2.54;DP=144;ExcessHet=3.0103;FS=2.956;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=26.39;ReadPosRankSum=-0.583;SOR=0.169	GT:AD:DP:GQ:PL	1/1:2,133:135:99:3577,381,0
chr16	88824063	88824063	C	T	GALNS	intronic	.	.	.	0.6073	GnomAdGenome_AF_eas	NA	NA	hom	627	18147.1	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.3735	0.6073	0.433906	0.0	0.377248	0.0		0.0					chr16	88824063	.	C	T	18147.1	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=28.94;AS_ReadPosRankSum=.;AS_SOR=0.722;DP=647;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.94;SOR=0.722	GT:AD:DP:GQ:PL	1/1:0,627:627:99:18161,1865,0
chr16	88824618	88824618	C	T	GALNS	intronic	.	.	.	0.6048	GnomAdGenome_AF_eas	33.0	15.0	hom	583	16362.1	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	not_provided	criteria_provided,_single_submitter	Benign	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.3894	0.6048	0.449481	0.0	0.386699	0.41744	PASS	0.0	0.379	69.0	0.366667	14.0	chr16	88824618	.	C	T	16362.1	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=-0.2;AS_FS=0;AS_MQ=60;AS_MQRankSum=0;AS_QD=28.07;AS_ReadPosRankSum=-0.3;AS_SOR=0.357;BaseQRankSum=-0.115;DP=606;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=28.07;ReadPosRankSum=-0.244;SOR=0.357	GT:AD:DP:GQ:PL	1/1:1,582:583:99:16376,1701,0
chr16	88825320	88825320	A	G	GALNS	intronic	.	.	.	0.5997	GnomAdGenome_AF_eas	NA	NA	hom	145	3841.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.374	0.5997	0.374401	0.0	0.0082219	0.0		0.0					chr16	88825320	.	A	G	3841.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=0.8;AS_FS=0;AS_MQ=58.42;AS_MQRankSum=-0.5;AS_QD=26.49;AS_ReadPosRankSum=1.9;AS_SOR=1.179;BaseQRankSum=0.814;DP=159;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=58.42;MQRankSum=-0.483;QD=26.49;ReadPosRankSum=1.96;SOR=1.179	GT:AD:DP:GQ:PL	1/1:2,143:145:99:3855,375,0
chr16	88825395	88825395	G	A	GALNS	intronic	.	.	.	0.4833	GnomAdGenome_AF_eas	NA	NA	hom	184	4400.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.195	0.4833	0.262181	0.0	0.133395	0.0		0.0					chr16	88825395	.	G	A	4400.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=3.6;AS_FS=7.999;AS_MQ=58.66;AS_MQRankSum=0.2;AS_QD=23.91;AS_ReadPosRankSum=1.1;AS_SOR=1.063;BaseQRankSum=3.62;DP=190;ExcessHet=3.0103;FS=7.999;MLEAC=2;MLEAF=1;MQ=58.73;MQRankSum=0.21;QD=23.91;ReadPosRankSum=1.1;SOR=1.063	GT:AD:DP:GQ:PL	1/1:9,175:184:99:4414,412,0
chr16	88825535	88825580	GGGGCTGGGGTGCCTGGGTGTCCGGGACTGGGATTCCTGGGCAGCT	-	GALNS	intronic	.	.	.	0.5512	GnomAdGenome_AF_eas	NA	NA	hom	277	11112.0	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.2934	0.5512	0.0	0.0	0.016098	0.0		0.0					chr16	88825534	.	CGGGGCTGGGGTGCCTGGGTGTCCGGGACTGGGATTCCTGGGCAGCT	C	11112.0	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=59.68;AS_MQRankSum=-0.2;AS_QD=32.18;AS_ReadPosRankSum=.;AS_SOR=1.491;DP=352;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=59.58;MQRankSum=-0.173;QD=26.19;SOR=1.491	GT:AD:DP:GQ:PGT:PID:PL:PS	1|1:2,275:277:99:1|1:88825534_CGGGGCTGGGGTGCCTGGGTGTCCGGGACTGGGATTCCTGGGCAGCT_C:11126,813,0:88825534
chr16	88825741	88825741	G	T	GALNS	intronic	.	.	.	0.0	GnomAdExome_AF	NA	NA	het	654	4496.64	ReadPosRankSum-8	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0					chr16	88825741	.	G	T	4496.64	ReadPosRankSum-8	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-0.5;AS_FS=32.864;AS_MQ=60;AS_MQRankSum=0;AS_QD=6.88;AS_ReadPosRankSum=-8.5;AS_SOR=2.3;BaseQRankSum=-0.463;DP=664;ExcessHet=3.0103;FS=32.864;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=6.88;ReadPosRankSum=-8.485;SOR=2.3	GT:AD:DP:GQ:PGT:PID:PL:PS	0|1:487,167:654:99:0|1:88825741_G_T:4504,0,19405:88825741
chr16	88825746	88825746	-	TCCTCCCTGTCTTA	GALNS	intronic	.	.	.	0.0	GnomAdExome_AF	NA	NA	het	636	4281.6	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0					chr16	88825746	.	C	CTCCTCCCTGTCTTA	4281.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=4.3;AS_FS=33.632;AS_MQ=60;AS_MQRankSum=0;AS_QD=6.73;AS_ReadPosRankSum=-11.5;AS_SOR=2.464;BaseQRankSum=4.34;DP=640;ExcessHet=3.0103;FS=33.632;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=6.73;ReadPosRankSum=-11.5;SOR=2.464	GT:AD:DP:GQ:PGT:PID:PL:PS	0|1:479,157:636:99:0|1:88825741_G_T:4289,0,19340:88825741
chr16	88826605	88826605	C	G	GALNS	intronic	.	.	.	0.58	GnomAdGenome_AF_eas	31.0	23.0	hom	497	14024.1	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	not_provided	criteria_provided,_single_submitter	Benign	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.3366	0.58	0.404153	0.0	0.0001537	0.345395	PASS	0.0	0.345	83.0	0.361314	53.0	chr16	88826605	.	C	G	14024.1	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=28.22;AS_ReadPosRankSum=.;AS_SOR=0.755;DP=508;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.22;SOR=0.755	GT:AD:DP:GQ:PL	1/1:0,497:497:99:14038,1483,0
chr16	88826841	88826841	G	C	GALNS	intronic	.	.	.	3.84e-05	Kaviar_AF	NA	NA	hom	551	15647.1	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	Mucopolysaccharidosis,_MPS-IV-A	criteria_provided,_single_submitter	Uncertain_significance	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.9998	0.926	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.84e-05	0.0		0.0					chr16	88826841	.	G	C	15647.1	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=28.4;AS_ReadPosRankSum=.;AS_SOR=0.78;DP=568;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.4;SOR=0.78	GT:AD:DP:GQ:PL	1/1:0,551:551:99:15661,1643,0
chr16	88827008	88827008	A	G	GALNS	intronic	.	.	.	0.6566	GnomAdGenome_AF_eas	38.0	4.0	hom	555	15517.1	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	not_provided	criteria_provided,_single_submitter	Benign	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.3424	0.6566	0.427117	0.0	0.340787	0.375728	PASS	0.0	0.369	95.0	0.46875	7.0	chr16	88827008	.	A	G	15517.1	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=27.96;AS_ReadPosRankSum=.;AS_SOR=0.771;DP=567;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=27.96;SOR=0.771	GT:AD:DP:GQ:PL	1/1:0,555:555:99:15531,1646,0
chr16	88828224	88828224	T	C	GALNS	intronic	.	.	.	0.7212	GnomAdGenome_AF_eas	NA	NA	hom	268	7541.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.4766	0.7212	0.544529	0.0	0.438643	0.0		0.0					chr16	88828224	.	T	C	7541.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=28.14;AS_ReadPosRankSum=.;AS_SOR=0.978;DP=276;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.14;SOR=0.978	GT:AD:DP:GQ:PL	1/1:0,268:268:99:7555,800,0
chr16	88828992	88829030	GTCTCACGCCATCGTCTCCCAGACCTACGCGGGTCCCGA	-	GALNS	intronic	.	.	.	0.4973	GnomAdGenome_AF_eas	NA	NA	hom	307	11360.0	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.2577	0.4973	0.0	0.0	0.0002305	0.0		0.0					chr16	88828991	.	GGTCTCACGCCATCGTCTCCCAGACCTACGCGGGTCCCGA	G	11360.0	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=0.6;AS_FS=0;AS_MQ=57.53;AS_MQRankSum=-0.6;AS_QD=27.61;AS_ReadPosRankSum=-0.3;AS_SOR=0.767;BaseQRankSum=0.675;DP=372;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=57.99;MQRankSum=-0.555;QD=31.36;ReadPosRankSum=-0.213;SOR=0.767	GT:AD:DP:GQ:PGT:PID:PL:PS	1|1:2,305:307:99:1|1:88828991_GGTCTCACGCCATCGTCTCCCAGACCTACGCGGGTCCCGA_G:11374,899,0:88828991
chr16	88829059	88829059	A	G	GALNS	intronic	.	.	.	0.6089	GnomAdGenome_AF_eas	NA	NA	hom	317	11756.1	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.3364	0.6089	0.502396	0.0	0.300638	0.0		0.0					chr16	88829059	.	A	G	11756.1	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=57.21;AS_MQRankSum=.;AS_QD=37.83;AS_ReadPosRankSum=.;AS_SOR=0.712;DP=323;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=57.26;QD=27.63;SOR=0.712	GT:AD:DP:GQ:PGT:PID:PL:PS	1|1:0,317:317:99:1|1:88828991_GGTCTCACGCCATCGTCTCCCAGACCTACGCGGGTCCCGA_G:11770,951,0:88828991
chr16	88831170	88831170	C	G	GALNS	intronic	.	.	.	0.0256	GnomAdGenome_AF_asj	NA	NA	hom	353	9116.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0012	0.0256	0.000199681	0.0	0.0006531	0.0		0.0					chr16	88831170	.	C	G	9116.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=59.96;AS_MQRankSum=.;AS_QD=25.82;AS_ReadPosRankSum=.;AS_SOR=1.536;DP=357;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=59.96;QD=25.82;SOR=1.536	GT:AD:DP:GQ:PL	1/1:0,353:353:99:9130,1052,0
chr16	88832493	88832493	T	C	GALNS	intronic	.	.	.	0.6424	GnomAdGenome_AF_eas	NA	NA	hom	308	8465.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.2199	0.6424	0.298123	0.0	0.267251	0.0		0.0					chr16	88832493	.	T	C	8465.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=58.52;AS_MQRankSum=.;AS_QD=27.48;AS_ReadPosRankSum=.;AS_SOR=0.728;DP=314;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=27.48;SOR=0.728	GT:AD:DP:GQ:PL	1/1:0,308:308:99:8479,914,0
chr16	88832914	88832914	T	C	GALNS	intronic	.	.	.	0.5923	GnomAdGenome_AF_eas	NA	NA	hom	263	7523.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.2887	0.5923	0.350839	0.0	0.32246	0.0		0.0					chr16	88832914	.	T	C	7523.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=28.6;AS_ReadPosRankSum=.;AS_SOR=1.013;DP=272;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.6;SOR=1.013	GT:AD:DP:GQ:PL	1/1:0,263:263:99:7537,785,0
chr16	88833078	88833081	AAAA	-	GALNS	intronic	.	.	.	0.1082	GnomAdGenome_AF_sas	NA	NA	het	105	721.6	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0554	0.1082	0.0	0.0	0.0001153	0.0		0.0					chr16	88833077	.	CAAAA	C	721.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-2.3;AS_FS=3.189;AS_MQ=57.82;AS_MQRankSum=1.8;AS_QD=2.27;AS_ReadPosRankSum=1.9;AS_SOR=0.314;BaseQRankSum=-2.61;DP=161;ExcessHet=3.0103;FS=8.351;MLEAC=1;MLEAF=0.5;MQ=58.76;MQRankSum=3.46;QD=11.64;ReadPosRankSum=1.74;SOR=0.15	GT:AD:DP:GQ:PL	0/1:39,23:105:99:729,0,1120
chr16	88833427	88833427	-	CTT	GALNS	intronic	.	.	.	0.5696	GnomAdGenome_AF_eas	NA	NA	hom	221	9729.03	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.2965	0.5696	0.368211	0.0	0.0001537	0.0		0.0					chr16	88833427	.	C	CCTT	9729.03	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=28.47;AS_ReadPosRankSum=.;AS_SOR=1.012;DP=234;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=36.25;SOR=1.012	GT:AD:DP:GQ:PL	1/1:0,221:221:99:9743,665,0
chr16	88833450	88833450	-	C	GALNS	intronic	.	.	.	0.5711	GnomAdGenome_AF_eas	NA	NA	het	148	243.6	QD2	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.2181	0.5711	0.255192	0.0	0.0180191	0.0		0.0					chr16	88833450	.	T	TC	243.6	QD2	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=0.7;AS_FS=8.134;AS_MQ=60;AS_MQRankSum=1.2;AS_QD=1.65;AS_ReadPosRankSum=-0.2;AS_SOR=1.435;BaseQRankSum=0.743;DP=205;ExcessHet=3.0103;FS=8.134;MLEAC=1;MLEAF=0.5;MQ=59.4;MQRankSum=1.24;QD=1.65;ReadPosRankSum=-0.192;SOR=1.435	GT:AD:DP:GQ:PL	0/1:119,29:148:99:251,0,3494
chr16	88833455	88833456	TT	-	GALNS	intronic	.	.	.	0.0006	GnomAdGenome_AF_asj	NA	NA	het	155	603.6	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0001	0.0006	0.0	0.0	0.0002689	0.0		0.0					chr16	88833454	.	CTT	C	603.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-0.4;AS_FS=1.846;AS_MQ=60;AS_MQRankSum=1.3;AS_QD=1.32;AS_ReadPosRankSum=2.1;AS_SOR=0.495;BaseQRankSum=-0.524;DP=203;ExcessHet=3.0103;FS=8.254;MLEAC=1;MLEAF=0.5;MQ=59.2;MQRankSum=1.02;QD=5.64;ReadPosRankSum=2.65;SOR=0.54	GT:AD:DP:GQ:PL	0/1:81,26:155:99:611,0,3535
chr16	88833457	88833457	T	C	GALNS	intronic	.	.	.	9.976e-05	GnomAdGenome_AF_fin	NA	NA	het	168	233.64	QD2	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	7.082e-06	9.976e-05	0.0	0.0	0.0	0.0		0.0					chr16	88833457	.	T	C	233.64	QD2	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-0.7;AS_FS=0.799;AS_MQ=60;AS_MQRankSum=1.5;AS_QD=1.47;AS_ReadPosRankSum=2.2;AS_SOR=0.589;BaseQRankSum=-0.663;DP=200;ExcessHet=3.0103;FS=1.531;MLEAC=1;MLEAF=0.5;MQ=59.19;MQRankSum=1.09;QD=1.47;ReadPosRankSum=2.96;SOR=0.514	GT:AD:DP:GQ:PL	0/1:133,26:168:99:241,0,4301
chr16	88834331	88834331	A	G	GALNS	intronic	.	.	.	0.6049	GnomAdGenome_AF_eas	NA	NA	hom	149	3914.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.3017	0.6049	0.376797	0.0	0.0001537	0.0		0.0					chr16	88834331	.	A	G	3914.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=58.57;AS_MQRankSum=.;AS_QD=26.27;AS_ReadPosRankSum=.;AS_SOR=0.978;DP=155;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=58.62;QD=26.27;SOR=0.978	GT:AD:DP:GQ:PL	1/1:0,149:149:99:3928,437,0
chr16	88834357	88834357	C	-	GALNS	intronic	.	.	.	0.0014	GnomAdGenome_AF_oth	NA	NA	het	76	39.6	QD2	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0002	0.0014	0.0	0.0	0.0003842	0.0		0.0					chr16	88834356	.	GC	G	39.6	QD2	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-1.5;AS_FS=0;AS_MQ=55.42;AS_MQRankSum=-0.7;AS_QD=0.53;AS_ReadPosRankSum=1.1;AS_SOR=0.773;BaseQRankSum=-1.438;DP=106;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=56.24;MQRankSum=-0.604;QD=0.52;ReadPosRankSum=1.13;SOR=0.773	GT:AD:DP:GQ:PL	0/1:66,10:76:47:47,0,1684
chr16	88834431	88834433	TCA	-	GALNS	intronic	.	.	.	0.3421	GnomAdGenome_AF_eas	NA	NA	het	47	1525.6	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.128	0.3421	0.0	0.0	0.0026126	0.0		0.0					chr16	88834430	.	CTCA	C	1525.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=3;AS_FS=4.032;AS_MQ=47.1;AS_MQRankSum=0.6;AS_QD=32.47;AS_ReadPosRankSum=-1;AS_SOR=1.666;BaseQRankSum=3.02;DP=54;ExcessHet=3.0103;FS=4.032;MLEAC=1;MLEAF=0.5;MQ=45.86;MQRankSum=0.611;QD=32.46;ReadPosRankSum=-0.947;SOR=1.666	GT:AD:DP:GQ:PGT:PID:PL:PS	0|1:6,41:47:92:0|1:88834430_CTCA_C:1533,0,92:88834430
chr16	88834436	88834469	GTGGTCTGGGAAGAGGCTGTAGGGCCCCCCCCGT	-	GALNS	intronic	.	.	.	0.1771	GnomAdGenome_AF_eas	NA	NA	het	73	1447.6	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0972	0.1771	0.0	0.0	0.0005763	0.0		0.0					chr16	88834435	.	CGTGGTCTGGGAAGAGGCTGTAGGGCCCCCCCCGT	C	1447.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=3;AS_FS=19.824;AS_MQ=47.1;AS_MQRankSum=-1.2;AS_QD=19.84;AS_ReadPosRankSum=-1.5;AS_SOR=1.542;BaseQRankSum=3;DP=78;ExcessHet=3.0103;FS=19.824;MLEAC=1;MLEAF=0.5;MQ=48.07;MQRankSum=-1.185;QD=19.83;ReadPosRankSum=-1.42;SOR=1.542	GT:AD:DP:GQ:PGT:PID:PL:PS	0|1:32,41:73:99:0|1:88834430_CTCA_C:1455,0,946:88834430
chr16	88834461	88834461	C	0	GALNS	intronic	.	.	.	0.0	GnomAdExome_AF	NA	NA	het	63	577.04	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0					chr16	88834461	.	C	0	577.04	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=47.1;AS_MQRankSum=.;AS_QD=30.93;AS_ReadPosRankSum=.;AS_SOR=1.666;DP=67;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=48.72;QD=9.16;SOR=0.859	GT:AD:DP:GQ:PL	1/0:0,41:63:99:2064,587,846
chr16	88834461	88834461	C	T	GALNS	intronic	.	.	.	0.1789	GnomAdGenome_AF_eas	NA	NA	het	63	577.04	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0424	0.1789	0.0	0.0	0.017097	0.0		0.0					chr16	88834461	.	C	T	577.04	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=51.81;AS_MQRankSum=.;AS_QD=26.23;AS_ReadPosRankSum=.;AS_SOR=1.931;DP=67;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=48.72;QD=9.16;SOR=0.859	GT:AD:DP:GQ:PL	0/1:0,22:63:99:2064,1536,1471
chr16	88834602	88834602	C	T	GALNS	intronic	.	.	.	0.2362	GnomAdGenome_AF_eas	NA	NA	het	91	654.64	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0668	0.2362	0.0	0.0	0.0020747	0.0		0.0					chr16	88834602	.	C	T	654.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-0.1;AS_FS=0;AS_MQ=51.63;AS_MQRankSum=-0.1;AS_QD=7.2;AS_ReadPosRankSum=2;AS_SOR=0.767;BaseQRankSum=-0.016;DP=94;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=51.74;MQRankSum=-0.022;QD=7.19;ReadPosRankSum=2.08;SOR=0.767	GT:AD:DP:GQ:PL	0/1:52,39:91:99:662,0,932
chr16	88835442	88835442	T	A	GALNS	intronic	.	.	.	0.6006	GnomAdGenome_AF_eas	50.0	33.0	hom	308	8635.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	not_provided	criteria_provided,_single_submitter	Benign	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.3881	0.6006	0.453075	0.0	0.0727352	0.418719	PASS	0.0	0.439	108.0	0.464539	65.0	chr16	88835442	.	T	A	8635.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=28.04;AS_ReadPosRankSum=.;AS_SOR=1.053;DP=321;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.04;SOR=1.053	GT:AD:DP:GQ:PL	1/1:0,308:308:99:8649,914,0
chr16	88835775	88835775	G	A	GALNS	exonic	synonymous SNV	.	GALNS:NM_001323543:exon6:c.C153T:p.H51H,GALNS:NM_000512:exon7:c.C708T:p.H236H,GALNS:NM_001323544:exon8:c.C726T:p.H242H	0.5701	GnomAdGenome_AF_eas	81.0	12.0	hom	280	7859.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	Benign	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	Mucopolysaccharidosis,_MPS-IV-A|not_specified|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	Benign	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.2801	0.5698	0.5764	0.2494	0.5701	0.316693	0.2405	0.271193	0.261905	PASS	0.366485	0.288	318.0	0.302817	62.0	chr16	88835775	.	G	A	7859.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=-0.3;AS_FS=3.073;AS_MQ=60;AS_MQRankSum=0;AS_QD=28.07;AS_ReadPosRankSum=1.7;AS_SOR=0.28;BaseQRankSum=-0.293;DP=296;ExcessHet=3.0103;FS=3.073;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=28.07;ReadPosRankSum=1.71;SOR=0.28	GT:AD:DP:GQ:PL	1/1:1,279:280:99:7873,804,0
chr16	88835868	88835868	C	T	GALNS	intronic	.	.	.	0.5699	GnomAdExome_AF_eas	66.0	11.0	hom	266	7731.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	Mucopolysaccharidosis,_MPS-IV-A|not_specified|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	Benign	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.2706	0.5699	0.5762	0.2106	0.5688	0.276757	0.1988	0.256478	0.231527	PASS	0.0	0.287	289.0	0.288732	60.0	chr16	88835868	.	C	T	7731.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=29.06;AS_ReadPosRankSum=.;AS_SOR=0.708;DP=270;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.06;SOR=0.708	GT:AD:DP:GQ:PL	1/1:0,266:266:99:7745,794,0
chr16	88836063	88836063	G	T	GALNS	intronic	.	.	.	0.5894	GnomAdGenome_AF_eas	31.0	12.0	hom	176	7527.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	not_provided	criteria_provided,_single_submitter	Benign	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.38	0.5894	0.453674	0.0	0.320885	0.417241	PASS	0.0	0.349	54.0	0.34375	20.0	chr16	88836063	.	G	T	7527.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=59.74;AS_MQRankSum=.;AS_QD=26.45;AS_ReadPosRankSum=.;AS_SOR=1.356;DP=182;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=59.63;QD=31.54;SOR=1.356	GT:AD:DP:GQ:PGT:PID:PL:PS	1|1:0,176:176:99:1|1:88836063_G_T:7541,529,0:88836063
chr16	88836076	88836076	T	C	GALNS	intronic	.	.	.	0.5946	GnomAdGenome_AF_eas	31.0	12.0	hom	181	7930.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	not_provided	criteria_provided,_single_submitter	Benign	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.3893	0.5946	0.460064	0.0	0.0662475	0.42602	PASS	0.0	0.34	53.0	0.358333	19.0	chr16	88836076	.	T	C	7930.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=25.51;AS_ReadPosRankSum=.;AS_SOR=1.154;DP=182;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=59.9;QD=32.24;SOR=1.154	GT:AD:DP:GQ:PGT:PID:PL:PS	1|1:0,181:181:99:1|1:88836063_G_T:7944,545,0:88836063
chr16	88836110	88836110	A	G	GALNS	intronic	.	.	.	0.5975	GnomAdGenome_AF_eas	25.0	22.0	hom	197	7504.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	not_provided	criteria_provided,_single_submitter	Benign	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.3414	0.5975	0.407149	0.0	0.0610212	0.354949	PASS	0.0	0.295	48.0	0.35	47.0	chr16	88836110	.	A	G	7504.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=26.15;AS_ReadPosRankSum=.;AS_SOR=0.703;DP=198;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.4;SOR=0.703	GT:AD:DP:GQ:PGT:PID:PL:PS	1|1:0,197:197:99:1|1:88836063_G_T:7518,589,0:88836063
chr16	88836372	88836372	A	G	GALNS	intronic	.	.	.	0.6012	GnomAdGenome_AF_eas	32.0	24.0	hom	292	8336.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	not_provided	criteria_provided,_single_submitter	Benign	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.2841	0.6012	0.357228	0.0	0.0583304	0.305921	PASS	0.0	0.355	85.0	0.408451	68.0	chr16	88836372	.	A	G	8336.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=28.55;AS_ReadPosRankSum=.;AS_SOR=0.721;DP=301;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=59.99;QD=28.55;SOR=0.721	GT:AD:DP:GQ:PL	1/1:0,292:292:99:8350,872,0
chr16	88836412	88836412	T	C	GALNS	intronic	.	.	.	0.5718	GnomAdGenome_AF_eas	17.0	11.0	hom	277	12058.1	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	not_provided	criteria_provided,_single_submitter	Benign	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.2513	0.5718	0.315096	0.0	0.273398	0.260762	PASS	0.0	0.268	78.0	0.289855	58.0	chr16	88836412	.	T	C	12058.1	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=59.99;AS_MQRankSum=.;AS_QD=30.69;AS_ReadPosRankSum=.;AS_SOR=0.715;DP=280;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=59.99;QD=33.35;SOR=0.715	GT:AD:DP:GQ:PL	1/1:0,277:277:99:12072,833,0
chr16	88836415	88836415	G	T	GALNS	intronic	.	.	.	0.5685	GnomAdGenome_AF_eas	17.0	11.0	hom	271	7799.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	not_provided	criteria_provided,_single_submitter	Benign	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.2511	0.5685	0.314696	0.0	0.272975	0.26412	PASS	0.0	0.268	78.0	0.285714	58.0	chr16	88836415	.	G	T	7799.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=2.5;AS_FS=3.026;AS_MQ=59.99;AS_MQRankSum=-0.1;AS_QD=28.78;AS_ReadPosRankSum=-0.1;AS_SOR=0.119;BaseQRankSum=2.56;DP=277;ExcessHet=3.0103;FS=3.026;MLEAC=2;MLEAF=1;MQ=59.99;MQRankSum=-0.043;QD=28.78;ReadPosRankSum=-0.027;SOR=0.119	GT:AD:DP:GQ:PL	1/1:2,269:271:99:7813,791,0
chr16	88836657	88836657	A	-	GALNS	intronic	.	.	.	0.007	GnomAdGenome_AF_fin	NA	NA	het	162	819.6	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0013	0.007	0.0	0.0	0.0003458	0.0		0.0					chr16	88836656	.	GA	G	819.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=0.2;AS_FS=0.727;AS_MQ=60;AS_MQRankSum=0;AS_QD=4.73;AS_ReadPosRankSum=1.5;AS_SOR=0.778;BaseQRankSum=-0.811;DP=211;ExcessHet=3.0103;FS=2.901;MLEAC=1;MLEAF=0.5;MQ=59.89;MQRankSum=0;QD=7.52;ReadPosRankSum=1.01;SOR=0.969	GT:AD:DP:GQ:PL	0/1:65,44:162:99:827,0,1682
chr16	88837146	88837146	G	A	GALNS	intronic	.	.	.	0.5627	GnomAdGenome_AF_eas	NA	NA	hom	319	8840.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.2439	0.5627	0.311701	0.0	0.266598	0.0		0.0					chr16	88837146	.	G	A	8840.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=27.71;AS_ReadPosRankSum=.;AS_SOR=0.819;DP=330;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=27.71;SOR=0.819	GT:AD:DP:GQ:PL	1/1:0,319:319:99:8854,951,0
chr16	88837388	88837388	C	A	GALNS	intronic	.	.	.	0.5961	GnomAdGenome_AF_eas	20.0	NA	hom	326	9491.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	not_provided	criteria_provided,_single_submitter	Benign	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.282	0.5961	0.356829	0.0	0.308206	0.298177	PASS	0.0	0.201	14.0			chr16	88837388	.	C	A	9491.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=1.8;AS_FS=0;AS_MQ=60;AS_MQRankSum=0;AS_QD=29.11;AS_ReadPosRankSum=1.4;AS_SOR=0.246;BaseQRankSum=1.85;DP=335;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=29.11;ReadPosRankSum=1.48;SOR=0.246	GT:AD:DP:GQ:PL	1/1:1,325:326:99:9505,964,0
chr16	88837488	88837488	C	T	GALNS	intronic	.	.	.	0.5641	GnomAdGenome_AF_eas	13.0	10.0	hom	321	9073.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	not_provided	criteria_provided,_single_submitter	Benign	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.2584	0.5641	0.328674	0.0	0.271823	0.261618	PASS	0.0	0.236	57.0	0.266129	13.0	chr16	88837488	.	C	T	9073.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=28.26;AS_ReadPosRankSum=.;AS_SOR=0.818;DP=328;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.26;SOR=0.818	GT:AD:DP:GQ:PL	1/1:0,321:321:99:9087,952,0
chr16	88839290	88839290	A	C	GALNS	intronic	.	.	.	0.6113	GnomAdGenome_AF_eas	NA	NA	hom	76	2027.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.327	0.6113	0.388578	0.0	0.0001537	0.0		0.0					chr16	88839290	.	A	C	2027.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=58.87;AS_MQRankSum=.;AS_QD=26.67;AS_ReadPosRankSum=.;AS_SOR=0.801;DP=80;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=58.61;QD=26.67;SOR=0.801	GT:AD:DP:GQ:PL	1/1:0,76:76:99:2041,224,0
chr16	88839480	88839480	C	T	GALNS	intronic	.	.	.	0.5759	GnomAdGenome_AF_eas	NA	NA	hom	128	3592.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.2346	0.5759	0.302716	0.0	0.26314	0.0		0.0					chr16	88839480	.	C	T	3592.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=28.06;AS_ReadPosRankSum=.;AS_SOR=0.895;DP=132;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.06;SOR=0.895	GT:AD:DP:GQ:PL	1/1:0,128:128:99:3606,381,0
chr16	88840147	88840147	C	A	GALNS	intronic	.	.	.	0.5665	GnomAdGenome_AF_eas	NA	NA	hom	157	4448.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.2108	0.5665	0.273962	0.0	0.0094514	0.0		0.0					chr16	88840147	.	C	A	4448.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=28.33;AS_ReadPosRankSum=.;AS_SOR=0.87;DP=160;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.33;SOR=0.87	GT:AD:DP:GQ:PL	1/1:0,157:157:99:4462,467,0
chr16	88840372	88840372	A	G	GALNS	intronic	.	.	.	0.5777	GnomAdGenome_AF_eas	NA	NA	hom	97	2609.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.2366	0.5777	0.302915	0.0	0.264945	0.0		0.0					chr16	88840372	.	A	G	2609.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=26.9;AS_ReadPosRankSum=.;AS_SOR=1.609;DP=102;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=26.9;SOR=1.609	GT:AD:DP:GQ:PL	1/1:0,97:97:99:2623,284,0
chr16	88840635	88840635	A	G	GALNS	intronic	.	.	.	0.5767	GnomAdGenome_AF_eas	13.0	NA	hom	137	3653.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.3056	0.5767	0.374401	0.0	0.288651	0.0		0.0	0.194	30.0			chr16	88840635	.	A	G	3653.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=26.66;AS_ReadPosRankSum=.;AS_SOR=0.831;DP=141;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=26.66;SOR=0.831	GT:AD:DP:GQ:PL	1/1:0,137:137:99:3667,408,0
chr16	88840875	88840875	G	T	GALNS	intronic	.	.	.	0.6325	GnomAdGenome_AF_afr	23.0	15.0	hom	144	4209.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	not_provided	criteria_provided,_single_submitter	Benign	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.402	0.6325	0.472644	0.0	0.337368	0.368637	PASS	0.0	0.293	93.0	0.309859	58.0	chr16	88840875	.	G	T	4209.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=29.23;AS_ReadPosRankSum=.;AS_SOR=0.721;DP=148;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.23;SOR=0.721	GT:AD:DP:GQ:PL	1/1:0,144:144:99:4223,428,0
chr16	88842620	88842620	C	T	GALNS	intronic	.	.	.	0.5646	GnomAdGenome_AF_eas	16.0	10.0	hom	120	3426.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	not_provided	criteria_provided,_single_submitter	Benign	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.2106	0.5646	0.273363	0.0	0.251268	0.227422	PASS	0.0	0.255	75.0	0.262411	54.0	chr16	88842620	.	C	T	3426.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=28.55;AS_ReadPosRankSum=.;AS_SOR=0.693;DP=123;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.55;SOR=0.693	GT:AD:DP:GQ:PL	1/1:0,120:120:99:3440,358,0
chr16	88842687	88842687	G	A	GALNS	intronic	.	.	.	0.3471	GnomAdGenome_AF_ami	28.0	3.0	hom	123	3439.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	Mucopolysaccharidosis,_MPS-IV-A|not_specified|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	Benign	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.1472	0.1673	0.166	0.1339	0.3471	0.109625	0.1429	0.142249	0.157635	PASS	0.0	0.154	197.0	0.137324	33.0	chr16	88842687	.	G	A	3439.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=27.96;AS_ReadPosRankSum=.;AS_SOR=0.742;DP=126;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=27.96;SOR=0.742	GT:AD:DP:GQ:PL	1/1:0,123:123:99:3453,365,0
chr16	88843380	88843380	C	T	GALNS	intronic	.	.	.	0.5672	GnomAdGenome_AF_eas	14.0	1.0	hom	147	4061.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.207	0.5672	0.273363	0.0	0.249116	0.0		0.0	0.254	59.0	0.1875	4.0	chr16	88843380	.	C	T	4061.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=27.63;AS_ReadPosRankSum=.;AS_SOR=0.948;DP=153;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=27.63;SOR=0.948	GT:AD:DP:GQ:PL	1/1:0,147:147:99:4075,436,0
chr16	88843751	88843751	-	CTGT	GALNS	intronic	.	.	.	0.6512	GnomAdGenome_AF_eas	NA	NA	hom	135	6060.03	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.3777	0.6512	0.45008	0.0	0.244199	0.0		0.0					chr16	88843751	.	G	GCTGT	6060.03	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=32.79;AS_ReadPosRankSum=.;AS_SOR=0.708;DP=142;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=31.96;SOR=0.708	GT:AD:DP:GQ:PGT:PID:PL:PS	1|1:0,135:135:99:1|1:88843751_G_GCTGT:6074,406,0:88843751
chr16	88843754	88843754	A	G	GALNS	intronic	.	.	.	0.652	GnomAdGenome_AF_eas	NA	NA	hom	139	6159.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.3779	0.652	0.465455	0.0	0.169241	0.0		0.0					chr16	88843754	.	A	G	6159.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=31.53;AS_ReadPosRankSum=.;AS_SOR=0.737;DP=142;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=32.54;SOR=0.737	GT:AD:DP:GQ:PGT:PID:PL:PS	1|1:0,139:139:99:1|1:88843751_G_GCTGT:6173,418,0:88843751
chr16	88843781	88843782	TA	-	GALNS	intronic	.	.	.	0.6527	GnomAdGenome_AF_eas	NA	NA	hom	130	5740.03	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.4109	0.6527	0.5002	0.0	0.0578223	0.0		0.0					chr16	88843780	.	TTA	T	5740.03	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=30.17;AS_ReadPosRankSum=.;AS_SOR=0.822;DP=136;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=34.11;SOR=0.822	GT:AD:DP:GQ:PGT:PID:PL:PS	1|1:0,130:130:99:1|1:88843780_TTA_T:5754,391,0:88843780
chr16	88843789	88843789	A	G	GALNS	intronic	.	.	.	0.6533	GnomAdGenome_AF_eas	NA	NA	hom	142	6098.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.4109	0.6533	0.5002	0.0	0.0102198	0.0		0.0					chr16	88843789	.	A	G	6098.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=29.89;AS_ReadPosRankSum=.;AS_SOR=0.721;DP=147;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=30.51;SOR=0.721	GT:AD:DP:GQ:PGT:PID:PL:PS	1|1:0,142:142:99:1|1:88843780_TTA_T:6112,427,0:88843780
chr16	88853252	88853254	AAA	-	GALNS	intronic	.	.	.	0.0706	GnomAdGenome_AF_nfe	NA	NA	het	16	171.6	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0462	0.0706	0.0	0.0	0.0001153	0.0		0.0					chr16	88853251	.	CAAA	C	171.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=1.8;AS_FS=0;AS_MQ=55.68;AS_MQRankSum=-0.6;AS_QD=5.54;AS_ReadPosRankSum=1.4;AS_SOR=0.446;BaseQRankSum=2.31;DP=42;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=58.6;MQRankSum=-0.063;QD=13.2;ReadPosRankSum=1.72;SOR=0.446	GT:AD:DP:GQ:PL	0/1:9,4:16:99:179,0,461
chr16	88854268	88854268	C	G	GALNS	intronic	.	.	.	0.5614	GnomAdGenome_AF_afr	NA	NA	hom	113	4918.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.3282	0.5614	0.408147	0.0	0.206547	0.0		0.0					chr16	88854268	.	C	G	4918.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=30.8;AS_ReadPosRankSum=.;AS_SOR=0.711;DP=115;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=32.2;SOR=0.711	GT:AD:DP:GQ:PGT:PID:PL:PS	1|1:0,113:113:99:1|1:88854268_C_G:4932,340,0:88854268
chr16	88854269	88854269	C	T	GALNS	intronic	.	.	.	0.594	GnomAdGenome_AF_afr	NA	NA	hom	113	4918.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.3487	0.594	0.422923	0.0	0.0012294	0.0		0.0					chr16	88854269	.	C	T	4918.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=31.41;AS_ReadPosRankSum=.;AS_SOR=0.711;DP=117;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.08;SOR=0.711	GT:AD:DP:GQ:PGT:PID:PL:PS	1|1:0,113:113:99:1|1:88854268_C_G:4932,340,0:88854268
chr16	88855226	88855226	C	G	GALNS	intronic	.	.	.	0.5918	GnomAdExome_AF_afr	50.0	7.0	hom	69	1925.06	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	Mucopolysaccharidosis,_MPS-IV-A	criteria_provided,_single_submitter	Benign	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.3013	0.5918	0.6074	0.3792	0.5789	0.400759	0.0	0.0766872	0.0		0.0	0.239	279.0	0.208633	44.0	chr16	88855226	.	C	G	1925.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=27.9;AS_ReadPosRankSum=.;AS_SOR=1.296;DP=73;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=27.9;SOR=1.296	GT:AD:DP:GQ:PL	1/1:0,69:69:99:1939,205,0
chr16	88856581	88856581	-	C	GALNS	intronic	.	.	.	0.6635	GnomAdGenome_AF_afr	7.0	10.0	hom	25	760.03	PASS	.	[MIM:253000]Mucopolysaccharidosis 4A [recessive?];	612222	.	Mucopolysaccharidosis type 4A	Disease-causing germline mutation(s) in	Hair color[26926045];	HP:0002673;HP:0003300;HP:0003307;HP:0000670;HP:0001223;HP:0003621;HP:0000687;HP:0001388;HP:0000904;HP:0002318;HP:0000365;HP:0003521;HP:0000683;HP:0003016;HP:0003053;HP:0012070;HP:0000939;HP:0003311;HP:0012069;HP:0002091;HP:0000154;HP:0000007;HP:0000280;HP:0000303;HP:0003277;HP:0001654;HP:0002808;HP:0000884;HP:0002788;HP:0000023;HP:0003049;HP:0002240;HP:0003308;HP:0030865;HP:0000926;HP:0002650;HP:0002857;HP:0007759	Coxa valga;Ovoid vertebral bodies;Hyperlordosis;Carious teeth;Pointed proximal second through fifth metacarpals;Juvenile onset;Widely spaced teeth;Joint laxity;Flaring of rib cage;Cervical myelopathy;Hearing impairment;Disproportionate short-trunk short stature;Grayish enamel;Metaphyseal widening;Epiphyseal deformities of tubular bones;Chondroitin sulfate excretion in urine;Osteoporosis;Hypoplasia of the odontoid process;Keratan sulfate excretion in urine;Restrictive ventilatory defect;Wide mouth;Autosomal recessive inheritance;Coarse facial features;Mandibular prognathia;Constricted iliac wings;Abnormal heart valve morphology;Kyphosis;Prominent sternum;Recurrent upper respiratory tract infections;Inguinal hernia;Ulnar deviation of the wrist;Hepatomegaly;Cervical subluxation;Large elbow;Platyspondyly;Scoliosis;Genu valgum;Opacification of the corneal stroma	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	alveolus;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;head and neck;mammary gland;mesenchyma;cervix;fovea centralis;hippocampus;cartilage;bone;brain;blood;bone marrow;lung;ovary;thyroid;macula lutea;lymph node;frontal lobe;colon;placenta;aorta;prostate;breast;optic nerve;	superior cervical ganglion;trigeminal ganglion;	0.0838	N	N	N	N	0.966653866947246	E	Galns	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.4784	0.6635	0.465256	0.0	0.0003074	0.304636	PASS	0.0	0.121	18.0	0.151261	16.0	chr16	88856581	.	A	AC	760.03	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=30.4;AS_ReadPosRankSum=.;AS_SOR=5.058;DP=36;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=30.4;SOR=5.058	GT:AD:DP:GQ:PL	1/1:0,25:25:75:774,75,0
chr17	42537437	42537437	T	C	NAGLU	exonic	synonymous SNV	.	NAGLU:NM_000263:exon2:c.T423C:p.S141S	1.0	GnomAdExome_AF_eas	832.0	140.0	hom	99	2858.06	PASS	.	[MIM:616491]Charcot-Marie-Tooth disease 2V [dominant?];	609701	Benign	Autosomal dominant Charcot-Marie-Tooth disease type 2V;Sanfilippo syndrome type B	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in	Inflammatory bowel disease[28067908];Systolic blood pressure change trajectories[27980656];Crohn's disease[28067908];Ulcerative colitis[28067908];	HP:0002936;HP:0003676;HP:0000006;HP:0001265;HP:0003401;HP:0010871;HP:0001387;HP:0000007;HP:0002788;HP:0003309;HP:0001249;HP:0001007;HP:0000752;HP:0002240;HP:0003621;HP:0000664;HP:0002159;HP:0001670;HP:0001744;HP:0000250;HP:0000280;HP:0000718;HP:0001640;HP:0002360;HP:0000943;HP:0002208;HP:0002344;HP:0000365;HP:0002014;HP:0001250;HP:0000900	Distal sensory impairment;Progressive;Autosomal dominant inheritance;Hyporeflexia;Paresthesia;Sensory ataxia;Joint stiffness;Autosomal recessive inheritance;Recurrent upper respiratory tract infections;Ovoid thoracolumbar vertebrae;Intellectual disability;Hirsutism;Hyperactivity;Hepatomegaly;Juvenile onset;Synophrys;Heparan sulfate excretion in urine;Asymmetric septal hypertrophy;Splenomegaly;Dense calvaria;Coarse facial features;Aggressive behavior;Cardiomegaly;Sleep disturbance;Dysostosis multiplex;Coarse hair;Progressive neurologic deterioration;Hearing impairment;Diarrhea;Seizure;Thickened ribs	Mucopolysaccharidosis,_MPS-III-B|Charcot-Marie-Tooth_disease,_axonal_type_2V|not_specified|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Liver, ovary, peripheral blood leukocytes, testis, prostate, spleen, colon, lung, placenta and kidney.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	epididymis;skin;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;muscle;head and neck;mammary gland;visual apparatus;cervix;fovea centralis;liver;cartilage;bone;parathyroid;brain;blood;heart;lung;ovary;macula lutea;colon;placenta;prostate;optic nerve;hypothalamus;	ciliary ganglion;testis - interstitial;trigeminal ganglion;skeletal muscle;	0.159	N	N	N	N	0.731134820473446	E	Naglu	cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; vision/eye phenotype; hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); pigmentation phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); liver/biliary system phenotype; 	.	.	.	.	0.9945	1.0	1.0	0.9949	1.0	0.997604	0.9948	0.0012679	0.994253	PASS	1.0	0.999	2.0	0.992958	2.0	chr17	42537437	.	T	C	2858.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=28.87;AS_ReadPosRankSum=.;AS_SOR=0.797;DP=102;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.87;SOR=0.797	GT:AD:DP:GQ:PL	1/1:0,99:99:99:2872,297,0
chr17	42537595	42537595	G	C	NAGLU	intronic	.	.	.	0.8391	GnomAdExome_AF_amr	170.0	47.0	hom	48	1437.06	PASS	.	[MIM:616491]Charcot-Marie-Tooth disease 2V [dominant?];	609701	.	Autosomal dominant Charcot-Marie-Tooth disease type 2V;Sanfilippo syndrome type B	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in	Inflammatory bowel disease[28067908];Systolic blood pressure change trajectories[27980656];Crohn's disease[28067908];Ulcerative colitis[28067908];	HP:0002936;HP:0003676;HP:0000006;HP:0001265;HP:0003401;HP:0010871;HP:0001387;HP:0000007;HP:0002788;HP:0003309;HP:0001249;HP:0001007;HP:0000752;HP:0002240;HP:0003621;HP:0000664;HP:0002159;HP:0001670;HP:0001744;HP:0000250;HP:0000280;HP:0000718;HP:0001640;HP:0002360;HP:0000943;HP:0002208;HP:0002344;HP:0000365;HP:0002014;HP:0001250;HP:0000900	Distal sensory impairment;Progressive;Autosomal dominant inheritance;Hyporeflexia;Paresthesia;Sensory ataxia;Joint stiffness;Autosomal recessive inheritance;Recurrent upper respiratory tract infections;Ovoid thoracolumbar vertebrae;Intellectual disability;Hirsutism;Hyperactivity;Hepatomegaly;Juvenile onset;Synophrys;Heparan sulfate excretion in urine;Asymmetric septal hypertrophy;Splenomegaly;Dense calvaria;Coarse facial features;Aggressive behavior;Cardiomegaly;Sleep disturbance;Dysostosis multiplex;Coarse hair;Progressive neurologic deterioration;Hearing impairment;Diarrhea;Seizure;Thickened ribs	Mucopolysaccharidosis,_MPS-III-B|Charcot-Marie-Tooth_disease,_axonal_type_2V|not_specified|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Liver, ovary, peripheral blood leukocytes, testis, prostate, spleen, colon, lung, placenta and kidney.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	epididymis;skin;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;muscle;head and neck;mammary gland;visual apparatus;cervix;fovea centralis;liver;cartilage;bone;parathyroid;brain;blood;heart;lung;ovary;macula lutea;colon;placenta;prostate;optic nerve;hypothalamus;	ciliary ganglion;testis - interstitial;trigeminal ganglion;skeletal muscle;	0.159	N	N	N	N	0.731134820473446	E	Naglu	cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; vision/eye phenotype; hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); pigmentation phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); liver/biliary system phenotype; 	.	.	.	.	0.7374	0.8391	0.8392	0.7456	0.8217	0.720048	0.7454	0.70468	0.748768	PASS	0.0	0.594	236.0	0.59507	75.0	chr17	42537595	.	G	C	1437.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=59.37;AS_MQRankSum=.;AS_QD=29.94;AS_ReadPosRankSum=.;AS_SOR=2.56;DP=49;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.94;SOR=2.56	GT:AD:DP:GQ:PL	1/1:0,48:48:99:1451,144,0
chr17	42537861	42537861	A	-	NAGLU	intronic	.	.	.	0.0066	GnomAdGenome_AF_fin	NA	NA	het	32	126.6	PASS	.	[MIM:616491]Charcot-Marie-Tooth disease 2V [dominant?];	609701	.	Autosomal dominant Charcot-Marie-Tooth disease type 2V;Sanfilippo syndrome type B	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in	Inflammatory bowel disease[28067908];Systolic blood pressure change trajectories[27980656];Crohn's disease[28067908];Ulcerative colitis[28067908];	HP:0002936;HP:0003676;HP:0000006;HP:0001265;HP:0003401;HP:0010871;HP:0001387;HP:0000007;HP:0002788;HP:0003309;HP:0001249;HP:0001007;HP:0000752;HP:0002240;HP:0003621;HP:0000664;HP:0002159;HP:0001670;HP:0001744;HP:0000250;HP:0000280;HP:0000718;HP:0001640;HP:0002360;HP:0000943;HP:0002208;HP:0002344;HP:0000365;HP:0002014;HP:0001250;HP:0000900	Distal sensory impairment;Progressive;Autosomal dominant inheritance;Hyporeflexia;Paresthesia;Sensory ataxia;Joint stiffness;Autosomal recessive inheritance;Recurrent upper respiratory tract infections;Ovoid thoracolumbar vertebrae;Intellectual disability;Hirsutism;Hyperactivity;Hepatomegaly;Juvenile onset;Synophrys;Heparan sulfate excretion in urine;Asymmetric septal hypertrophy;Splenomegaly;Dense calvaria;Coarse facial features;Aggressive behavior;Cardiomegaly;Sleep disturbance;Dysostosis multiplex;Coarse hair;Progressive neurologic deterioration;Hearing impairment;Diarrhea;Seizure;Thickened ribs	.	.	.	Liver, ovary, peripheral blood leukocytes, testis, prostate, spleen, colon, lung, placenta and kidney.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	epididymis;skin;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;muscle;head and neck;mammary gland;visual apparatus;cervix;fovea centralis;liver;cartilage;bone;parathyroid;brain;blood;heart;lung;ovary;macula lutea;colon;placenta;prostate;optic nerve;hypothalamus;	ciliary ganglion;testis - interstitial;trigeminal ganglion;skeletal muscle;	0.159	N	N	N	N	0.731134820473446	E	Naglu	cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; vision/eye phenotype; hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); pigmentation phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); liver/biliary system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0012	0.0066	0.0	0.0	0.0001153	0.0		0.0					chr17	42537860	.	TA	T	126.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=2.3;AS_FS=1.957;AS_MQ=60;AS_MQRankSum=0;AS_QD=4.29;AS_ReadPosRankSum=0.8;AS_SOR=0.283;BaseQRankSum=3.16;DP=47;ExcessHet=3.0103;FS=1.527;MLEAC=1;MLEAF=0.5;MQ=59.29;MQRankSum=-0.556;QD=7.45;ReadPosRankSum=0.692;SOR=0.425	GT:AD:DP:GQ:PL	0/1:9,8:32:99:134,0,192
chr17	42538100	42538100	G	C	NAGLU	intronic	.	.	.	0.8174	GnomAdGenome_AF_asj	63.0	NA	hom	96	2896.06	PASS	.	[MIM:616491]Charcot-Marie-Tooth disease 2V [dominant?];	609701	.	Autosomal dominant Charcot-Marie-Tooth disease type 2V;Sanfilippo syndrome type B	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in	Inflammatory bowel disease[28067908];Systolic blood pressure change trajectories[27980656];Crohn's disease[28067908];Ulcerative colitis[28067908];	HP:0002936;HP:0003676;HP:0000006;HP:0001265;HP:0003401;HP:0010871;HP:0001387;HP:0000007;HP:0002788;HP:0003309;HP:0001249;HP:0001007;HP:0000752;HP:0002240;HP:0003621;HP:0000664;HP:0002159;HP:0001670;HP:0001744;HP:0000250;HP:0000280;HP:0000718;HP:0001640;HP:0002360;HP:0000943;HP:0002208;HP:0002344;HP:0000365;HP:0002014;HP:0001250;HP:0000900	Distal sensory impairment;Progressive;Autosomal dominant inheritance;Hyporeflexia;Paresthesia;Sensory ataxia;Joint stiffness;Autosomal recessive inheritance;Recurrent upper respiratory tract infections;Ovoid thoracolumbar vertebrae;Intellectual disability;Hirsutism;Hyperactivity;Hepatomegaly;Juvenile onset;Synophrys;Heparan sulfate excretion in urine;Asymmetric septal hypertrophy;Splenomegaly;Dense calvaria;Coarse facial features;Aggressive behavior;Cardiomegaly;Sleep disturbance;Dysostosis multiplex;Coarse hair;Progressive neurologic deterioration;Hearing impairment;Diarrhea;Seizure;Thickened ribs	not_provided	criteria_provided,_single_submitter	Benign	Liver, ovary, peripheral blood leukocytes, testis, prostate, spleen, colon, lung, placenta and kidney.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	epididymis;skin;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;muscle;head and neck;mammary gland;visual apparatus;cervix;fovea centralis;liver;cartilage;bone;parathyroid;brain;blood;heart;lung;ovary;macula lutea;colon;placenta;prostate;optic nerve;hypothalamus;	ciliary ganglion;testis - interstitial;trigeminal ganglion;skeletal muscle;	0.159	N	N	N	N	0.731134820473446	E	Naglu	cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; vision/eye phenotype; hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); pigmentation phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); liver/biliary system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.7454	0.8174	0.720048	0.0	0.731405	0.760073	PASS	0.0	0.553	19.0			chr17	42538100	.	G	C	2896.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=30.17;AS_ReadPosRankSum=.;AS_SOR=0.919;DP=97;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=30.17;SOR=0.919	GT:AD:DP:GQ:PL	1/1:0,96:96:99:2910,288,0
chr17	42540114	42540114	A	-	NAGLU	intronic	.	.	.	0.0217652	1000g2015aug_all	NA	NA	het	26	189.6	PASS	.	[MIM:616491]Charcot-Marie-Tooth disease 2V [dominant?];	609701	.	Autosomal dominant Charcot-Marie-Tooth disease type 2V;Sanfilippo syndrome type B	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in	Inflammatory bowel disease[28067908];Systolic blood pressure change trajectories[27980656];Crohn's disease[28067908];Ulcerative colitis[28067908];	HP:0002936;HP:0003676;HP:0000006;HP:0001265;HP:0003401;HP:0010871;HP:0001387;HP:0000007;HP:0002788;HP:0003309;HP:0001249;HP:0001007;HP:0000752;HP:0002240;HP:0003621;HP:0000664;HP:0002159;HP:0001670;HP:0001744;HP:0000250;HP:0000280;HP:0000718;HP:0001640;HP:0002360;HP:0000943;HP:0002208;HP:0002344;HP:0000365;HP:0002014;HP:0001250;HP:0000900	Distal sensory impairment;Progressive;Autosomal dominant inheritance;Hyporeflexia;Paresthesia;Sensory ataxia;Joint stiffness;Autosomal recessive inheritance;Recurrent upper respiratory tract infections;Ovoid thoracolumbar vertebrae;Intellectual disability;Hirsutism;Hyperactivity;Hepatomegaly;Juvenile onset;Synophrys;Heparan sulfate excretion in urine;Asymmetric septal hypertrophy;Splenomegaly;Dense calvaria;Coarse facial features;Aggressive behavior;Cardiomegaly;Sleep disturbance;Dysostosis multiplex;Coarse hair;Progressive neurologic deterioration;Hearing impairment;Diarrhea;Seizure;Thickened ribs	.	.	.	Liver, ovary, peripheral blood leukocytes, testis, prostate, spleen, colon, lung, placenta and kidney.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	epididymis;skin;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;muscle;head and neck;mammary gland;visual apparatus;cervix;fovea centralis;liver;cartilage;bone;parathyroid;brain;blood;heart;lung;ovary;macula lutea;colon;placenta;prostate;optic nerve;hypothalamus;	ciliary ganglion;testis - interstitial;trigeminal ganglion;skeletal muscle;	0.159	N	N	N	N	0.731134820473446	E	Naglu	cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; vision/eye phenotype; hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); pigmentation phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); liver/biliary system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0028	0.0077	0.0217652	0.0	0.0008837	0.0		0.0					chr17	42540113	.	CA	C	189.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=1;AS_FS=2.059;AS_MQ=60;AS_MQRankSum=0.8;AS_QD=5.2;AS_ReadPosRankSum=-0.5;AS_SOR=1.402;BaseQRankSum=0.974;DP=47;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=59.84;MQRankSum=1.92;QD=12.64;ReadPosRankSum=-0.414;SOR=1.127	GT:AD:DP:GQ:PL	0/1:6,9:26:99:197,0,111
chr17	42540400	42540400	A	-	NAGLU	intronic	.	.	.	0.0756	GnomAdGenome_AF_afr	NA	NA	het	58	455.6	PASS	.	[MIM:616491]Charcot-Marie-Tooth disease 2V [dominant?];	609701	.	Autosomal dominant Charcot-Marie-Tooth disease type 2V;Sanfilippo syndrome type B	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in	Inflammatory bowel disease[28067908];Systolic blood pressure change trajectories[27980656];Crohn's disease[28067908];Ulcerative colitis[28067908];	HP:0002936;HP:0003676;HP:0000006;HP:0001265;HP:0003401;HP:0010871;HP:0001387;HP:0000007;HP:0002788;HP:0003309;HP:0001249;HP:0001007;HP:0000752;HP:0002240;HP:0003621;HP:0000664;HP:0002159;HP:0001670;HP:0001744;HP:0000250;HP:0000280;HP:0000718;HP:0001640;HP:0002360;HP:0000943;HP:0002208;HP:0002344;HP:0000365;HP:0002014;HP:0001250;HP:0000900	Distal sensory impairment;Progressive;Autosomal dominant inheritance;Hyporeflexia;Paresthesia;Sensory ataxia;Joint stiffness;Autosomal recessive inheritance;Recurrent upper respiratory tract infections;Ovoid thoracolumbar vertebrae;Intellectual disability;Hirsutism;Hyperactivity;Hepatomegaly;Juvenile onset;Synophrys;Heparan sulfate excretion in urine;Asymmetric septal hypertrophy;Splenomegaly;Dense calvaria;Coarse facial features;Aggressive behavior;Cardiomegaly;Sleep disturbance;Dysostosis multiplex;Coarse hair;Progressive neurologic deterioration;Hearing impairment;Diarrhea;Seizure;Thickened ribs	.	.	.	Liver, ovary, peripheral blood leukocytes, testis, prostate, spleen, colon, lung, placenta and kidney.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	epididymis;skin;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;muscle;head and neck;mammary gland;visual apparatus;cervix;fovea centralis;liver;cartilage;bone;parathyroid;brain;blood;heart;lung;ovary;macula lutea;colon;placenta;prostate;optic nerve;hypothalamus;	ciliary ganglion;testis - interstitial;trigeminal ganglion;skeletal muscle;	0.159	N	N	N	N	0.731134820473446	E	Naglu	cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; vision/eye phenotype; hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); pigmentation phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); liver/biliary system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0293	0.0756	0.0	0.0	0.0001537	0.0		0.0					chr17	42540399	.	TA	T	455.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=0.6;AS_FS=4.36;AS_MQ=60;AS_MQRankSum=0;AS_QD=6.19;AS_ReadPosRankSum=-0.5;AS_SOR=1.402;BaseQRankSum=1.12;DP=74;ExcessHet=3.0103;FS=5.661;MLEAC=1;MLEAF=0.5;MQ=59.8;MQRankSum=-0.746;QD=10.85;ReadPosRankSum=0.385;SOR=1.547	GT:AD:DP:GQ:PL	0/1:22,20:58:99:463,0,410
chr17	42540696	42540696	A	-	NAGLU	intronic	.	.	.	0.371795	abraom_freq	NA	NA	het	29	228.6	PASS	.	[MIM:616491]Charcot-Marie-Tooth disease 2V [dominant?];	609701	.	Autosomal dominant Charcot-Marie-Tooth disease type 2V;Sanfilippo syndrome type B	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in	Inflammatory bowel disease[28067908];Systolic blood pressure change trajectories[27980656];Crohn's disease[28067908];Ulcerative colitis[28067908];	HP:0002936;HP:0003676;HP:0000006;HP:0001265;HP:0003401;HP:0010871;HP:0001387;HP:0000007;HP:0002788;HP:0003309;HP:0001249;HP:0001007;HP:0000752;HP:0002240;HP:0003621;HP:0000664;HP:0002159;HP:0001670;HP:0001744;HP:0000250;HP:0000280;HP:0000718;HP:0001640;HP:0002360;HP:0000943;HP:0002208;HP:0002344;HP:0000365;HP:0002014;HP:0001250;HP:0000900	Distal sensory impairment;Progressive;Autosomal dominant inheritance;Hyporeflexia;Paresthesia;Sensory ataxia;Joint stiffness;Autosomal recessive inheritance;Recurrent upper respiratory tract infections;Ovoid thoracolumbar vertebrae;Intellectual disability;Hirsutism;Hyperactivity;Hepatomegaly;Juvenile onset;Synophrys;Heparan sulfate excretion in urine;Asymmetric septal hypertrophy;Splenomegaly;Dense calvaria;Coarse facial features;Aggressive behavior;Cardiomegaly;Sleep disturbance;Dysostosis multiplex;Coarse hair;Progressive neurologic deterioration;Hearing impairment;Diarrhea;Seizure;Thickened ribs	not_provided	criteria_provided,_single_submitter	Likely_benign	Liver, ovary, peripheral blood leukocytes, testis, prostate, spleen, colon, lung, placenta and kidney.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	epididymis;skin;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;muscle;head and neck;mammary gland;visual apparatus;cervix;fovea centralis;liver;cartilage;bone;parathyroid;brain;blood;heart;lung;ovary;macula lutea;colon;placenta;prostate;optic nerve;hypothalamus;	ciliary ganglion;testis - interstitial;trigeminal ganglion;skeletal muscle;	0.159	N	N	N	N	0.731134820473446	E	Naglu	cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; vision/eye phenotype; hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); pigmentation phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); liver/biliary system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0051	0.0201	0.0	0.0	0.0003458	0.371795	PASS	0.0					chr17	42540695	.	CA	C	228.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-0.3;AS_FS=4.32;AS_MQ=60;AS_MQRankSum=0;AS_QD=7.3;AS_ReadPosRankSum=0.7;AS_SOR=1.06;BaseQRankSum=-0.792;DP=50;ExcessHet=3.0103;FS=9.751;MLEAC=1;MLEAF=0.5;MQ=59.98;MQRankSum=0;QD=11.43;ReadPosRankSum=1.65;SOR=1.593	GT:AD:DP:GQ:PL	0/1:9,11:29:99:236,0,177
chr17	42541326	42541326	C	T	NAGLU	intronic	.	.	.	0.9997	GnomAdGenome_AF_eas	164.0	61.0	hom	115	3394.06	PASS	.	[MIM:616491]Charcot-Marie-Tooth disease 2V [dominant?];	609701	.	Autosomal dominant Charcot-Marie-Tooth disease type 2V;Sanfilippo syndrome type B	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in	Inflammatory bowel disease[28067908];Systolic blood pressure change trajectories[27980656];Crohn's disease[28067908];Ulcerative colitis[28067908];	HP:0002936;HP:0003676;HP:0000006;HP:0001265;HP:0003401;HP:0010871;HP:0001387;HP:0000007;HP:0002788;HP:0003309;HP:0001249;HP:0001007;HP:0000752;HP:0002240;HP:0003621;HP:0000664;HP:0002159;HP:0001670;HP:0001744;HP:0000250;HP:0000280;HP:0000718;HP:0001640;HP:0002360;HP:0000943;HP:0002208;HP:0002344;HP:0000365;HP:0002014;HP:0001250;HP:0000900	Distal sensory impairment;Progressive;Autosomal dominant inheritance;Hyporeflexia;Paresthesia;Sensory ataxia;Joint stiffness;Autosomal recessive inheritance;Recurrent upper respiratory tract infections;Ovoid thoracolumbar vertebrae;Intellectual disability;Hirsutism;Hyperactivity;Hepatomegaly;Juvenile onset;Synophrys;Heparan sulfate excretion in urine;Asymmetric septal hypertrophy;Splenomegaly;Dense calvaria;Coarse facial features;Aggressive behavior;Cardiomegaly;Sleep disturbance;Dysostosis multiplex;Coarse hair;Progressive neurologic deterioration;Hearing impairment;Diarrhea;Seizure;Thickened ribs	not_provided	criteria_provided,_single_submitter	Benign	Liver, ovary, peripheral blood leukocytes, testis, prostate, spleen, colon, lung, placenta and kidney.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	epididymis;skin;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;muscle;head and neck;mammary gland;visual apparatus;cervix;fovea centralis;liver;cartilage;bone;parathyroid;brain;blood;heart;lung;ovary;macula lutea;colon;placenta;prostate;optic nerve;hypothalamus;	ciliary ganglion;testis - interstitial;trigeminal ganglion;skeletal muscle;	0.159	N	N	N	N	0.731134820473446	E	Naglu	cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; vision/eye phenotype; hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); pigmentation phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); liver/biliary system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.9599	0.9997	0.980431	0.0	0.185166	0.949097	PASS	0.0	0.991	3.0	0.948529	7.0	chr17	42541326	.	C	T	3394.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=29.51;AS_ReadPosRankSum=.;AS_SOR=0.941;DP=116;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.51;SOR=0.941	GT:AD:DP:GQ:PL	1/1:0,115:115:99:3408,344,0
chr17	42541906	42541906	T	-	NAGLU	intronic	.	.	.	0.0068	GnomAdGenome_AF_fin	NA	NA	het	73	389.6	PASS	.	[MIM:616491]Charcot-Marie-Tooth disease 2V [dominant?];	609701	.	Autosomal dominant Charcot-Marie-Tooth disease type 2V;Sanfilippo syndrome type B	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in	Inflammatory bowel disease[28067908];Systolic blood pressure change trajectories[27980656];Crohn's disease[28067908];Ulcerative colitis[28067908];	HP:0002936;HP:0003676;HP:0000006;HP:0001265;HP:0003401;HP:0010871;HP:0001387;HP:0000007;HP:0002788;HP:0003309;HP:0001249;HP:0001007;HP:0000752;HP:0002240;HP:0003621;HP:0000664;HP:0002159;HP:0001670;HP:0001744;HP:0000250;HP:0000280;HP:0000718;HP:0001640;HP:0002360;HP:0000943;HP:0002208;HP:0002344;HP:0000365;HP:0002014;HP:0001250;HP:0000900	Distal sensory impairment;Progressive;Autosomal dominant inheritance;Hyporeflexia;Paresthesia;Sensory ataxia;Joint stiffness;Autosomal recessive inheritance;Recurrent upper respiratory tract infections;Ovoid thoracolumbar vertebrae;Intellectual disability;Hirsutism;Hyperactivity;Hepatomegaly;Juvenile onset;Synophrys;Heparan sulfate excretion in urine;Asymmetric septal hypertrophy;Splenomegaly;Dense calvaria;Coarse facial features;Aggressive behavior;Cardiomegaly;Sleep disturbance;Dysostosis multiplex;Coarse hair;Progressive neurologic deterioration;Hearing impairment;Diarrhea;Seizure;Thickened ribs	.	.	.	Liver, ovary, peripheral blood leukocytes, testis, prostate, spleen, colon, lung, placenta and kidney.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	epididymis;skin;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;muscle;head and neck;mammary gland;visual apparatus;cervix;fovea centralis;liver;cartilage;bone;parathyroid;brain;blood;heart;lung;ovary;macula lutea;colon;placenta;prostate;optic nerve;hypothalamus;	ciliary ganglion;testis - interstitial;trigeminal ganglion;skeletal muscle;	0.159	N	N	N	N	0.731134820473446	E	Naglu	cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; vision/eye phenotype; hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); pigmentation phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); liver/biliary system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0028	0.0068	0.0	0.0	1.94e-05	0.0		0.0					chr17	42541905	.	AT	A	389.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-1.5;AS_FS=1.019;AS_MQ=60;AS_MQRankSum=0;AS_QD=6.74;AS_ReadPosRankSum=0.7;AS_SOR=0.544;BaseQRankSum=-0.973;DP=87;ExcessHet=3.0103;FS=4.528;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=6.84;ReadPosRankSum=0.696;SOR=0.937	GT:AD:DP:GQ:PL	0/1:35,22:73:99:397,0,819
chr17	42543226	42543226	T	C	NAGLU	exonic	nonsynonymous SNV	.	NAGLU:NM_000263:exon6:c.T1220C:p.L407P	0.0	GnomAdExome_AF	NA	NA	hom	93	2484.06	PASS	28.6	[MIM:616491]Charcot-Marie-Tooth disease 2V [dominant?];	609701	Uncertain significance	Autosomal dominant Charcot-Marie-Tooth disease type 2V;Sanfilippo syndrome type B	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in	Inflammatory bowel disease[28067908];Systolic blood pressure change trajectories[27980656];Crohn's disease[28067908];Ulcerative colitis[28067908];	HP:0002936;HP:0003676;HP:0000006;HP:0001265;HP:0003401;HP:0010871;HP:0001387;HP:0000007;HP:0002788;HP:0003309;HP:0001249;HP:0001007;HP:0000752;HP:0002240;HP:0003621;HP:0000664;HP:0002159;HP:0001670;HP:0001744;HP:0000250;HP:0000280;HP:0000718;HP:0001640;HP:0002360;HP:0000943;HP:0002208;HP:0002344;HP:0000365;HP:0002014;HP:0001250;HP:0000900	Distal sensory impairment;Progressive;Autosomal dominant inheritance;Hyporeflexia;Paresthesia;Sensory ataxia;Joint stiffness;Autosomal recessive inheritance;Recurrent upper respiratory tract infections;Ovoid thoracolumbar vertebrae;Intellectual disability;Hirsutism;Hyperactivity;Hepatomegaly;Juvenile onset;Synophrys;Heparan sulfate excretion in urine;Asymmetric septal hypertrophy;Splenomegaly;Dense calvaria;Coarse facial features;Aggressive behavior;Cardiomegaly;Sleep disturbance;Dysostosis multiplex;Coarse hair;Progressive neurologic deterioration;Hearing impairment;Diarrhea;Seizure;Thickened ribs	.	.	.	Liver, ovary, peripheral blood leukocytes, testis, prostate, spleen, colon, lung, placenta and kidney.;	D	D	D	D	D	D	H	D	D	D	D	D	D	D	D	D	D	D	.;	D	D	Alpha-N-acetylglucosaminidase, tim-barrel domain	.	.	Medium	Medium	Medium	epididymis;skin;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;muscle;head and neck;mammary gland;visual apparatus;cervix;fovea centralis;liver;cartilage;bone;parathyroid;brain;blood;heart;lung;ovary;macula lutea;colon;placenta;prostate;optic nerve;hypothalamus;	ciliary ganglion;testis - interstitial;trigeminal ganglion;skeletal muscle;	0.159	N	N	N	N	0.731134820473446	E	Naglu	cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; vision/eye phenotype; hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); pigmentation phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); liver/biliary system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0					chr17	42543226	.	T	C	2484.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=26.71;AS_ReadPosRankSum=.;AS_SOR=1.061;DP=99;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=26.71;SOR=1.061	GT:AD:DP:GQ:PL	1/1:0,93:93:99:2498,276,0
chr17	42544215	42544215	C	G	NAGLU	exonic	nonsynonymous SNV	.	NAGLU:NM_000263:exon6:c.C2209G:p.R737G	0.9994	GnomAdGenome_AF_eas	737.0	123.0	hom	97	2667.06	PASS	21.6	[MIM:616491]Charcot-Marie-Tooth disease 2V [dominant?];	609701	Benign	Autosomal dominant Charcot-Marie-Tooth disease type 2V;Sanfilippo syndrome type B	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in	Inflammatory bowel disease[28067908];Systolic blood pressure change trajectories[27980656];Crohn's disease[28067908];Ulcerative colitis[28067908];	HP:0002936;HP:0003676;HP:0000006;HP:0001265;HP:0003401;HP:0010871;HP:0001387;HP:0000007;HP:0002788;HP:0003309;HP:0001249;HP:0001007;HP:0000752;HP:0002240;HP:0003621;HP:0000664;HP:0002159;HP:0001670;HP:0001744;HP:0000250;HP:0000280;HP:0000718;HP:0001640;HP:0002360;HP:0000943;HP:0002208;HP:0002344;HP:0000365;HP:0002014;HP:0001250;HP:0000900	Distal sensory impairment;Progressive;Autosomal dominant inheritance;Hyporeflexia;Paresthesia;Sensory ataxia;Joint stiffness;Autosomal recessive inheritance;Recurrent upper respiratory tract infections;Ovoid thoracolumbar vertebrae;Intellectual disability;Hirsutism;Hyperactivity;Hepatomegaly;Juvenile onset;Synophrys;Heparan sulfate excretion in urine;Asymmetric septal hypertrophy;Splenomegaly;Dense calvaria;Coarse facial features;Aggressive behavior;Cardiomegaly;Sleep disturbance;Dysostosis multiplex;Coarse hair;Progressive neurologic deterioration;Hearing impairment;Diarrhea;Seizure;Thickened ribs	Mucopolysaccharidosis,_MPS-III-B|Charcot-Marie-Tooth_disease,_axonal_type_2V|not_specified|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Liver, ovary, peripheral blood leukocytes, testis, prostate, spleen, colon, lung, placenta and kidney.;	D	T	P	B	N	P	L	D	N	T	T	T	.	T	T	T	T	T	.;	D	.	.	.	.	Medium	Medium	Medium	epididymis;skin;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;muscle;head and neck;mammary gland;visual apparatus;cervix;fovea centralis;liver;cartilage;bone;parathyroid;brain;blood;heart;lung;ovary;macula lutea;colon;placenta;prostate;optic nerve;hypothalamus;	ciliary ganglion;testis - interstitial;trigeminal ganglion;skeletal muscle;	0.159	N	N	N	N	0.731134820473446	E	Naglu	cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; vision/eye phenotype; hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); pigmentation phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); liver/biliary system phenotype; 	.	.	.	.	0.9108	0.9986	0.9987	0.8463	0.9994	0.859225	0.8488	0.879187	0.868552	PASS	0.0	0.941	96.0	0.933099	19.0	chr17	42544215	.	C	G	2667.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=27.49;AS_ReadPosRankSum=.;AS_SOR=0.799;DP=97;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=27.5;SOR=0.799	GT:AD:DP:GQ:PL	1/1:0,97:97:99:2681,290,0
